header logo image


Page 24«..1020..23242526..30..»

Archive for the ‘Genetic Engineering’ Category

This Week’s Awesome Tech Stories From Around the Web (Through January 11) – Singularity Hub

Saturday, January 11th, 2020

ARTIFICIAL INTELLIGENCE

Can an AI Be an Inventor? Not Yet.Angela Chen | MIT Technology Review[Ryan Abbott] believes there will be more and more cases where AI should be considered a genuine inventor and that the law needs to be ready. At stake in this discussion is the future of innovation, he says. Not allowing AI be recognized as an inventor is not only morally problematic, he says, but will lead to unintended consequences.

The Superpowers of Super-Thin MaterialsAmos Zeeberg | The New York TimesAs researchers like [Toms Palacios] see it, two-dimensional materials will be the linchpin of the internet of everything. They will be painted on bridges and form the sensors to watch for strain and cracks. They will cover windows with transparent layers that become visible only when information is displayed. Increasingly, the future looks flat.

Panasonics VR Glasses Support HDR and Look Pretty SteampunkSam Byford | The VergeThe problem with VR headsets is that they still all look like VR headsetsglorified ski goggles that shut you off from the world. my main takeaway from the demo was that hey, turns out its possible to make VR glasses that are both better qualityand with a better form factor.

Why the Quantum Internet Should Be Built in SpaceEmerging Technology From the arXiv | MIT Technology Review[Sumeet Khatri and colleagues have] studied the various ways a quantum internet could be built and say the most cost-effective approach is to create a constellation of quantum-enabled satellites capable of continuously broadcasting entangled photons to the ground. In other words, the quantum internet should be space-based.

The Gene Drive Dilemma: We Can Alter Entire Species, but Should We?Jennifer Kahn | The New York Times MagazineA new genetic engineering technology could help eliminate malaria and stave off extinctionsif humanity decides to unleash it.

Bots Are Destroying Political Discourse as We Know ItBruce Schneier | The AtlanticSoon, AI-driven personas will be able to write personalized letters to newspapers and elected officials, submit individual comments to public rule-making processes, and intelligently debate political issues on social media. They will be replicated in the millions and engage on the issues around the clock, sending billions of messages, long and short. Putting all this together, theyll be able to drown out any actual debate on the internet.

Image Credit: Karlis Reimanis /Unsplash

Continued here:
This Week's Awesome Tech Stories From Around the Web (Through January 11) - Singularity Hub

Read More...

Rural broadband and regenerative ag make waves in subcommittee hearing | 2020-01-09 – Agri-Pulse

Saturday, January 11th, 2020

Agricultural practices have the potential to address climate change by sequestering carbon,witnesses told a Housesubcommittee Thursday at a hearing focused on regenerative agriculture and ag technology.

David Potere, head of GeoInnovation at Indigo Agriculture,outlinedhow his company is creating a new market for a different type of crop: carbon. The company, which was founded in 2014, has begun an initiative to sequester 1 trillion tons of atmospheric carbon dioxide in farmland around the world, and through Indigo Carbon is offering farmers the opportunity to get paid for increasing the carbon content of their soil.

Bringing farmers into the solution can be a definitive part of the solution for climate change because of the potential of ag soils to absorb carbon, Potere told members of the House Innovation and Workforce Development Subcommittee.

Potere pointed totheEnergy Improvement and Extension Act of 2008, which contains a provision allowing oil companies to receive a tax incentive for carbon sequestration when they pull oil out of the ground. The way the act is currently written, farmers don't get the same incentive.

If there is broad bipartisan support for federal policy that incentivizes corporate, industrial and energy producers to sequester carbon, why cant the same support be there when farmers try and do the same?Potere said.

When asked about other ways growers can employ ag technology to make their farms more sustainable, witnesses offered a variety of suggestions.

Roberto Meza, co-founder of Emerald Gardens Microgreens in Bennett, Colo., touted the importance of channeling funding into regenerative agriculture practices to help develop innovative models for producing food.

Interested in more climate changecoverage and insights? Receive a free month of Agri-Pulse or Agri-Pulse West by clickinghere.

Kevin France, president and CEO of SWIIM Systems in Denver,said instead of asking the government to create somethingnew, it should make programssuch as the Environmental Quality Incentives Program more accessible to farmers.

Douglas Jackson-Smith, professor and assistant director of the school of environment and natural resources at Ohio State University, brought up the missed opportunity and regulatory hurdles surroundinggenetic engineering. He said there are many technologies that could benefit farmers and consumers but havent hadthe opportunity to enter the marketplace because of the current regulatory process set in place on genetic engineering.

Witnesses and members of Congress also used the occasion to call for improved rural connectivity. Subcommittee chairman Jason Crow, D-Colo., called connectivitythe backbone of ag tech," noting the ability ofbroadband to makeit possible for farmers to aggregate and analyze data in real time. He emphasized the need forgreater deployment of high-speed internet in rural communities to help ag technology thrive.

Potere commented on the impact rural broadband access has had on his company, sayingIndigo has had tobuildmobile technology that is resilient to the lack of internet connectivity. Creating this technology for farmers has required Indigo to increase itsdevelopment cost, something Potere said puts unnecessary financialpressure on the company, especiallywhen a simple solution such as rural broadband already exists.Farmers, he said, just lack access to it.

For more news, go to http://www.Agri-Pulse.com.

Read more:
Rural broadband and regenerative ag make waves in subcommittee hearing | 2020-01-09 - Agri-Pulse

Read More...

Bayer and Azitra Partner to Harness the Human Skin Microbiome as a Source for New Natural Skin Care Products for Sensitive and Eczema-Prone Skin -…

Saturday, January 11th, 2020

LEVERKUSEN, Germany & FARMINGTON, Conn.--(BUSINESS WIRE)--Bayer and Azitra Inc., a clinical-stage medical dermatology biotech company, today announced a joint development agreement to collaborate in the identification and characterization of skin microbiome bacteria. The partnership will leverage Azitras proprietary panel of Staphylococcus epidermidis strains to identify potential candidates for the treatment of adverse skin conditions and diseases. Based on the results of the research partnership, Bayer plans to develop selected Staphylococcus epidermidis strains into new natural skin care products under a future License Agreement. Prospective areas of application include medicated skin care products for sensitive, eczema-prone skin as well as therapeutic products for skin diseases such as atopic dermatitis.

Recent scientific publications suggest that microorganisms such as bacteria and especially skin-friendly bacteria, commonly referred to as skin microbiome, can significantly contribute to the protection of the skin from hostile invasions. Additional positive effects include supporting the recovery from skin diseases such as atopic dermatitis, acne, and rosacea, and may also accelerate wound healing.

The skin microbiome offers a promising platform for the development and commercialization of natural skin care products more and more people are looking for. As Bayer is committed to the development of science-based consumer health products through our own research as well as external partnerships, were delighted to collaborate with Azitra. The company has already demonstrated tolerability of a selected Staphylococcus epidermidis strain in healthy volunteers and is now planning to start the clinical demonstration of efficacy, Heiko Schipper, Member of the Board of Management of Bayer AG and President of Bayer Consumer Health, comments on the new partnership.

Bayer, a global leader in innovative and trusted skincare solutions, will actively contribute to the research collaboration by providing suitable topical formulations that are able to maintain Staphylococcus epidermidis viability while showing excellent skin compatibility and sensorial performance.

"We are strongly committed to the potential of the microbiome to provide significant benefits for improved skin health and appearance and by working together with Bayer I am confident we can deliver on the promise of this technology," states Richard Andrews, President and CEO of Azitra.

Azitras versatile platform technology offers further screening options for beneficial strains appropriate for the treatment of dermatological diseases such as atopic dermatitis, acne or psoriasis. In addition, Bayer will review the use of Azitras genetically modified bacteria in Dermatology and other Consumer Health areas such as Nutritionals and Digestive Health.

About Azitra

Azitra, Inc. is a clinical-stage medical dermatology company that combines the power of the microbiome with cutting-edge genetic engineering to treat skin disease. The company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its pharmaceutical programs to treat cancer therapy associated skin rashes, targeted orphan indications and atopic dermatitis.Learn more at http://www.azitrainc.com

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to http://www.bayer.com.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayers public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Read more from the original source:
Bayer and Azitra Partner to Harness the Human Skin Microbiome as a Source for New Natural Skin Care Products for Sensitive and Eczema-Prone Skin -...

Read More...

Acepodia Announces FDA Clearance of IND for its NK Cell Therapy Drug Candidate ACE1702 to Treat Patients with HER2-expressing Solid Tumors |…

Saturday, January 11th, 2020

DetailsCategory: AntibodiesPublished on Thursday, 09 January 2020 19:01Hits: 627

ACE1702 is a potential off-the-shelf cell therapy developed using Acepodias Antibody-Cell Conjugation technology

SAN FRANCISCO, CA, USA and TAIPEI, Taiwan I January 09, 2020 I Acepodia, a biotechnology company developing cancer immunotherapy based on its novel ACC (Antibody Cell-Conjugation) technology platform, today announced it has received clearance of its Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to initiate a Phase 1 clinical study of its natural killer (NK) cell therapy and lead drug candidate ACE1702 in patients with HER2-expressing solid tumors.

The FDAs clearance of our IND for ACE1702 is a major milestone for Acepodia that represents an important initial validation of our ACC platform, which can link any antibody, including those that have already proven effective in targeting tumors, to proprietary off-the-shelf natural killer cell line (oNK cells) without the need for genetic engineering, said Sonny Hsiao, Ph.D., chief executive officer of Acepodia, and the inventor of ACC while at University of California, Berkeley. This novel approach allows us to circumvent the complexity and the limitations associated with CAR-T and traditional NK based cell therapies. ACC significantly improves manufacturing costs and has the potential to generate a cost-effective cancer treatment that can deliver increased benefit to patients. We look forward to advancing ACE1702 into its first clinical trial.

About ACE1702ACE1702 is Acepodias lead clinical product candidate developed from the Companys proprietary ACC platform. It targets human HER2-expressing solidtumors using anti-HER2 antibody conjugated oNK cells. ACE1702 has demonstrated enhanced tumor cellkilling activities both in vitro and in vivo, while maintaining a favorable safety profile in GLPtoxicology studies. In preclinical studies, ACE1702 has shown enhanced tumor-killing activities against HER2 IHC 1+, 2+ and 3+ human cancer cells.

About Acepodia Acepodia is a privately held US-Taiwan biotechnology company committed to developing safe, effective, and affordable immunotherapeutic medicines targeting diseases with significant unmet medical needs, with a primary focus on oncology. Acepodias proprietary ACC (Antibody Cell-Conjugation) technology platform links tumor targeting antibodies to the surface of a novel and proprietary human NK cell line that have been specifically selected for their potent antitumor activity. The ACC technology can be seamlessly combined with currently available antibodies allowing for the rapid development of new targeted therapies in multiple indications, without the need for genetic engineering.

SOURCE: Acepodia

Read more here:
Acepodia Announces FDA Clearance of IND for its NK Cell Therapy Drug Candidate ACE1702 to Treat Patients with HER2-expressing Solid Tumors |...

Read More...

SAB Biotherapeutics Announces Research Collaboration With CSL Behring – Business Wire

Saturday, January 11th, 2020

SIOUX FALLS, S.D.--(BUSINESS WIRE)--SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical development company advancing a new class of immunotherapies, today announced that it has entered into multiple collaboration and option agreements with global biotherapeutics leader CSL Behring. The collaborations will explore the possibility and the potential of new therapies to treat challenging autoimmune, infectious and idiopathic diseases by leveraging SABs DiversitAb platform.

SAB has developed a unique platform, through advanced genetic engineering, to naturally and rapidly produce large amounts of human antibodies without using human donors.

The agreement includes a research program which will investigate a potential new source for human immunoglobulin G (IgG). Human IgG is currently used for a number of immunological and neurological diseases including Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barre Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), and Multifocal Motor Neuropathy (MMN).

CSL Behring is a leader in the global immunoglobulins market, which has grown substantially over the last five years. Key factors fueling market growth include an aging population, increased emphasis on the diagnosis and treatment of immune diseases, and its increased use in new indications.

SAB Biotherapeutics has developed a very interesting and novel platform for the production of human immunoglobulins, said Dr. Andrew Nash, Senior Vice President, Research for CSL Behring. CSL Behring is committed to the continuous development of innovative therapies that address unmet needs for patients with rare and serious diseases. This collaboration will provide both companies an opportunity to explore the potential of these new approaches to positively impact areas of need.

CSL Behrings R&D footprint includes more than 1,700 scientists across the globe with an R&D investment exceeding $800 million in 2018 - 2019.

We are excited that CSL Behring has chosen to work with SAB Biotherapeutics to explore new immunotherapies leveraging our technology platform, said Dr. Eddie J. Sullivan, president, CEO and co-founder of SAB Biotherapeutics. We believe combining our unique human antibody development and production capabilities with CSL Behrings established immunoglobulin franchise and vast expertise in biopharmaceutical development will broaden therapeutic possibilities.

CSL Behring and SAB will share research program and related costs and plan to complete the initial phase in 2020. The collaboration may lead to subsequent development and commercialization agreements.

About SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc. (SAB), headquartered in Sioux Falls, S.D. is a clinical-stage, biopharmaceutical development company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. Utilizing some of the most complex genetic engineering and antibody science in the world, SAB has developed the only platform that can rapidly produce natural, highly targeted, high-potency, immunotherapies at commercial scale. The company is advancing programs in autoimmunity, infectious diseases, inflammation and exploratory oncology.

Continue reading here:
SAB Biotherapeutics Announces Research Collaboration With CSL Behring - Business Wire

Read More...

Poplar Trees Were Genetically Modified to Not Harm Air Quality Heres What Happened in Testing – SciTechDaily

Saturday, January 11th, 2020

The Oregon plantation in October 2014, the second year of growth. Credit: T. Rosenstiel, Portland State University

Field trials in the Northwest and Southwest show that poplar trees can be genetically modified to reduce negative impacts on air quality while leaving their growth potential virtually unchanged, says an Oregon State University researcher who collaborated on the study.

The findings, published today in the Proceedings of the National Academy of Sciences, are important because poplar plantations cover 9.4 million hectares globally more than double the land used 15 years ago. Poplars are fast-growing trees that are a source of biofuel and other products including paper, pallets, plywood and furniture frames.

A drawback of poplar plantations is that the trees are also a major producer of isoprene, the key component of natural rubber and a pre-pollutant.

The Arizona plantation in May 2013, during the first year of growth. Credit: D.J.P. Moore (University of Arizona)

Increases in isoprene negatively affect regional air quality and also unbalance the global energy budget by leading to higher levels of atmospheric aerosol production, more ozone in the air and longer methane life. Ozone and methane are greenhouse gases, and ozone is also a respiratory irritant.

Poplar and other trees including oak, eucalyptus, and conifers produce isoprene in their leaves in response to climate stress such as high temperatures.

A research collaboration led by scientists at the University of Arizona, the Institute of Biochemical Plant Pathology in Germany, Portland State University and OSU genetically modified poplars not to produce isoprene, then tested them in three-year trials at plantations in Oregon and Arizona.

They found that trees whose isoprene production was genetically suppressed did not suffer any ill effects in terms of photosynthesis or biomass production they were able to make fuel and grow as well as trees that were producing isoprene.

Steve Strauss, distinguished professor of forest biotechnology in the OSU College of Forestry, said there are a couple of possible explanations for the findings.

One is that, without the ability to produce isoprene, the modified poplars appear to be making compensatory protective compounds.

Another is that most of the trees growth takes place during cooler times of the year, so heat stress, which triggers isoprene production, likely has little effect on photosynthesis at that time.

Our findings suggest that isoprene emissions can be diminished without affecting biomass production in temperate forest plantations, Strauss said. Thats what we wanted to examine can you turn down isoprene production, and does it matter to biomass productivity and general plant health? It looks like it doesnt impair either significantly. In Arizona, where its super hot, if isoprene mattered to productivity, it would show up in a striking way, but it did not. Plants are smart theyll compensate and do something different if they need to.

Measurements being collected on a representative tree at the Arizona plantation, June 2013. Credit: D.J.P. Moore (University of Arizona)

In this study, scientists used a genetic engineering tool known as RNA interference. RNA, ribonucleic acid, transmits protein coding instructions from each cells DNA, deoxyribonucleic acid, which holds the organisms genetic code.

RNA interference is like a vaccination it triggers a natural and highly specific mechanism whereby specific targets are suppressed, be they the RNA of viruses or endogenous genes, Strauss said. You can also do this with CRISPR at the DNA level, and it usually works even better.

CRISPR, short for clustered regularly interspaced short palindromic repeats, targets specific stretches of genetic code for DNA editing at exact locations.

You could also do the same thing through conventional breeding, Strauss said. It would be a lot less efficient and precise, and it might be a nightmare for breeders who may need to reassess all of their germplasm and possibly exclude their most productive cultivars as a result, but it could be done.

Corresponding author Russ Monson of the University of Arizona said the study lays the groundwork for future isoprene research, including in different growing environments.

The fact that cultivars of poplar can be produced in a way that ameliorates atmospheric impacts without significantly reducing biomass production gives us a lot of optimism, Monson said. Were striving toward greater environmental sustainability while developing plantation-scale biomass sources that can serve as fossil fuel alternatives. We also need to keep working toward solutions to the current regulatory and market roadblocks that make large-scale research and commercial uses for genetically engineered trees difficult.

Sustainable forest management systems and their certifying bodies operate under the assumption that genetically modified equates to dangerous, Strauss said.

If something is GMO, its guilty until proven safe in the minds of many and in our regulations today, he said. These technologies are new tools that require scientific research to evaluate and refine them on a case-by-case basis. We have a huge need for expanded production of sustainable and renewable forest products and ecological services, and biotechnologies can help meet that need.

###

Reference: High productivity in hybrid-poplar plantations without isoprene emission to the atmosphere by Russell K. Monson, Barbro Winkler, Todd N. Rosenstiel, Katja Block, Juliane Merl-Pham, Steven H. Strauss, Kori Ault, Jason Maxfield, David J. P. Moore, Nicole A. Trahan, Amberly A. Neice, Ian Shiach, Greg A. Barron-Gafford, Peter Ibsen, Joel T. McCorkel, Jrg Bernhardt and Joerg-Peter Schnitzler, 6 January 2020, Proceedings of the National Academy of Sciences.DOI: 10.1073/pnas.1912327117

Scientists from the University of California, Riverside, NASAs Goddard Space Flight Center, and the Institute for Microbiology in Greifswald, Germany, also collaborated on the study.

The National Science Foundation, the German Ministry of Education and Research, Portland General Electric, the U.S. Department of Agriculture, Portland State University, Oregon State University and the state of Arizona supported this research.

Read the original here:
Poplar Trees Were Genetically Modified to Not Harm Air Quality Heres What Happened in Testing - SciTechDaily

Read More...

Office of Technology Assessment: It’s time for a second coming | TheHill – The Hill

Saturday, January 11th, 2020

Congress must deal with a growing number of issues that new technological developments are forcing on the nation. I deliberately write forcing because the way technology works, no one asks the nation or its elected representatives if we need or want a given new technology. Any investor or engineer, these days more often a startup group or a tech corporation, can make the nation adapt to whatever they concoct.

For instance, a small group of young hotshot engineers is perfecting deep fake, a technology that enables one to make a video that will seem to be a very authentic presentation by a well-known politician, only it is completely made up. To consider the implications of this new gift to mankind, imagine that a day before the election, a candidate states that she has changed her mind and now favors something that will completely antagonize her base. By the time denials are issued and the truth comes out, the election may well be lost.

All of this does not point to the need for some licensing board to which technologists will have to apply before they can proceed but to a growing and urgent need for the nation to have the capacity to learn about new technological developments as early as possible, and prepare to deal with the consequences. And, possibly, in some rare cases well need to impose some restrictions on these developments.

Individual members of Congress and their staffs often do not have the resources, time or sufficient technical backgrounds to carry out such assessments. Hence the merit of recent moves to reestablish an Office of Technology Assessment (OTA) to play a major role in preparing technological assessments for Congress.

Last April Rep. Tim RyanTimothy (Tim) RyanOffice of Technology Assessment: It's time for a second coming Key moments in the 2020 Democratic presidential race so far GM among partners planning .3B battery plant in Ohio MORE (D-Ohio) included funding for OTA in a 2020 spending bill. But when the matter was discussed during a hearing of the House Committee on Science, Space and Technology in December, only a few members seemed to favor a full revival of the OTA.

The value of the defunct OTA is captured in an op-ed by Celia Wexler, the senior Washington representative at the Center for Science and Democracy. Wexler wrote:

The information they provided was used to make smart and applicable policy decisions. A 1984 study questioning the reliability of polygraph tests led Congress to enact limits on their use by employers. Another report from 1994 helped lawmakers assess the Social Security Administrations computer procurement plan, and ended up saving the government $368 million. OTA reports in 1987 and 1990, which concluded that Pap smears and mammograms for older women could save thousands of lives, were instrumental in extending Medicare reimbursement for these tests.

In 1972, Congress created the Office of Technology Assessment (OTA) to counsel senators and members of the House of Representatives on topics related to science and technology. Its ambitious goal was to give Congress technical expertise equal to that available to the executive branch through its many departments and agencies. The OTA board included representatives of both political parties and houses of Congress.

For over 20 years it produced approximately 750 reports dealing with issues raised by new technologies.

Congress defunded the OTA in 1995, keeping a promise that Rep. Newt GingrichNewton (Newt) Leroy GingrichMORE (R-Ga.) made during the successful Republican election campaign in 1994. Rep. Robert S. Walker (R-Pa.), who chaired the House Science Committee, disapproved of the OTA, argued that the pieces of legislation its reports were meant to inform often had to proceed without them due to the amount of time it took the OTA to produce a report.

The director of the agency acknowledged that it did not always finish reports in time to inform legislation. But he noted that agency researchers had testified about their work in progress at hearings and prepared less lengthy interim reports, when requested.

No single reason was given for the closing of the OTA. But some Republican lawmakers came to view it as duplicative, wasteful and biased against their party.

Another factor in the demise of OTA were, oddly, its neutrality. A former head of the OTA, Dr. John H. Gibbons, put it this way: If you belong to everyone, you belong to no one.

Another complaint was the dearth of public participation. Jathan Sadowski of the Consortium for Science, Policy & Outcomes at Arizona State University explained that [i]t did not adequately collect and examine the perspectives of a wider citizenryby, say, changing up their advisory panels or through methods like opinion polling and consensus conferences.

A major reason why the OTA must be revived is the accelerating pace of technological innovation, including in countries such as China. To illustrate, we need to assess the effect of AI (whether advanced in the U.S., China, Israel or elsewhere) on the destruction of jobs; the safety of driverless autos; the morality of the use of CRISPR for genetic engineering; facial recognition as a public safety tool; the impact of social media on democracy and society; and much more.

There seems to be ample work for at least one OTA. But it may well need to draw on the help of other organizations, such as the National Academy of Sciences, the NSF and DARPA.

Amitai Etzioni is a university professor and professor of international affairs at The George Washington University. Click here to watch a recent, four-minute video Political and Social Life after Trump. His latest book, Reclaiming Patriotism, was published by University of Virginia Press in 2019 and is available for download without charge.

View original post here:
Office of Technology Assessment: It's time for a second coming | TheHill - The Hill

Read More...

GM in India: Faking it on the Astroturf – Dissident Voice

Saturday, January 11th, 2020

According to arecent reportin The Hindu Business Line, Indias intelligence agencies are investigating the role of a global investment company and international seed companies in supporting farmers organisation Shetkari Sanghatana (SS) in the distribution of illegally procured genetically modified (GM) herbicide tolerant (HT) cotton seeds. The planting of such seeds is an offence under the Environment Protection Act and Seeds Act.

In May 2019, SS broke the law and freely distributed these seeds. In early January 2020, it broke the law again by distributing second generation seeds. According to the report, a senior intelligence official had toldBusiness Linethat a global investment company, with investments in seeds and agrochemicals companies, has chosen to support the farmers organisation.

Business Line reports that the investment company is allegedly putting pressure on the Modi government to ensure that the Genetic Engineering Appraisal Committee fast tracks the clearance of HT seeds, so the seeds could be legally harvested and sold in the country.

In India,five high-level reportshave advised against the adoption of GM crops. Appointed by the Supreme Court, the Technical Expert Committee (TEC) Final Report (2013) was scathing about the prevailing regulatory system and highlighted its inadequacies and serious inherent conflicts of interest. The TEC recommended a 10-year moratorium on the commercial release of all GM crops.

The reason why Bt cotton to date, Indias only officially approved GM crop made it into farmers fields in the first place was due to approval by contamination. Bt cotton was discovered in 2001 growing on thousands of hectares in Gujarat. In March 2002, it was approved for commercial cultivation.

The pro-GMO lobby has again resorted to such tactics. The 2010 moratorium on Bt brinjal was implemented because science won out against a regulatory process that lacked competency, possessed endemic conflicts of interest and demonstrated a lack of expertise in GM risk assessment protocols, including food safety assessment and the assessment of environmental impacts.

As we have seen with the relentless push to get GM mustard commercialised, the problems persist. Now, to justify breaking the law, we are seeing unscientific claims and well-worn industry-inspired soundbites about GM crops: political posturing unsupported by evidence to try to sway the policy agenda in favour of GM.

Drawing on previous peer-reviewed evidence, a2018 paperin the journal Current Science by renowned scientists PC Kesavan and MS Swaminathan concluded that Bt crops and HT crops are unsustainable and globally have not decreased the need for toxic chemical pesticides, the reason for these GM crops in the first place.

We need to look at GM objectively becauseplenty of evidenceindicates it poses risks or is not beneficial and that non-GM alternatives are a better option. Moreover, many things that scientists are trying to achieve with GM have already beensurpassed by means of conventional breeding.

Those behind the distribution and planting of illegal seeds talk about helping the farmer. But the real agenda is to open-up India to GM and get farmers hooked on a corporate money-spinning GM seed-chemical treadmill.

The watchdog GMWatch recently produced an article about how hired public relations agencies and key individuals with firm links to the biotechnology sector are attempting to deceive the public and policy makers. The articles author, Jonathan Matthews, notes that in June 2019 the pro-GMO campaignerMark Lynasbegantalking upwhat heclaimedwas to be the worlds first pro-GMO protest.

The term astroturfing is the process by which orchestrated marketing and public relations campaigns are presented as emanating from grassroots participants or ordinary members of the public rather than from powerful corporate interests.Lynas, a well-known industry lobbyist, said the protest would involve Indian farmers planting banned GM seeds in what hecalledGandhi-style civil disobedience. This attention-grabbing campaign was being led by SS, which Lynasdescribedas very grass roots.

According to Matthews, SS is not a mass movement of grassroots farmers but an allegedlywell-fundedfringe group created by the lateSharad Joshi, a right-wing economist andmemberof the Advisory Board of the Monsanto-backedWorld Agricultural Forum, an organisation whose founder and first chairman was for many years Monsantos director of public policy.

Joshi was also Chairman of Shivar Agroproducts Ltd, says Matthews, but he is best remembered for his ultra-libertarian ideology, his links to certain farmers groupsand the political party (Swatantra Bharat Paksh) that he founded all vehicles for promoting his free market fundamentalism.

Matthews says:

Lynas was not the first to present Shetkari Sanghatana as representing ordinary Indian farmers. A full two decades earlier, the European biotech industry and their PR firm Burson-Marsteller brought some of Shetkari Sanghatanas leading lights to Europe to try and counter the view that Indian farmers opposed GMO crops. To that end, they were toured around five different countries by the industrys lobby group, EuropaBio, which in a press releasepresented this free market fringe group, which islargelyconfined to the state of Maharashtra, as the mainstream farmers movement in India.

Matthews adds that the US is the biotech industrys chief propaganda hub for promoting wide-ranging fakery to the world. Referring to the illegal planting of HT cotton seeds and SS, he says:

Among the notable cheerleaders promoting the protesters cause were the Gates-backed GMO propaganda outfit The Alliance for Science, which paysMark Lynasto lobby for GMOs;CS PrakashofAgBioWorld, who has long served as a conduit forMonsanto disinformation;Bayer-consultantandMonsanto collaboratorKevin Folta, who made apodcaston the protests withCS Prakash

Matthews piece, Fake Farmer Willi part of an international fake parade, provides details of the various characters and strategies involved in faking it for the biotech industry, not just in India but across the world.

As a market for GM proprietary seeds, chemical inputs and agricultural technology and machinery, India is vast. The potential market for herbicide growth alone, for instance, is huge: sales could now have reached USD 800 million with scope for even greater expansion, especially with the illegal push to get HT seeds planted.

With GM crops largely shut out of Europe and many countries reluctant to embrace the technology, Western agro-biotech conglomerates are desperate to seek out and expand into untapped (foreign) markets to maintain profitability.India presents potential rich pickings. And this is the bottom line: GM is not about helping farmers or feeding the masses (myths that have been deconstructed time and again). It is about hard-nose interests endeavouring to displace existing systems of production and capturing and exploiting markets by any means possible not least fakery and deception.

This article was posted on Friday, January 10th, 2020 at 7:15pm and is filed under GMO, India.

Link:
GM in India: Faking it on the Astroturf - Dissident Voice

Read More...

With $110M to add to the bankroll, Generation Bio sets its sights on engineering a revolution in the gene therapy field – Endpoints News

Saturday, January 11th, 2020

Whoever comes out on top of the current race to gain pioneering approvals for new AAV-delivered gene therapies will have to look over their shoulders to watch the next tech wave forming on the horizon for gene therapy 2.0.

One of those next-gen players, Generation Bio, just brought in $110 million of venture cash to cover the cost of the rest of their preclinical journey toward something completely new in the field. The latest round brings the biotech which now has about 80 staffers up to $235 million in total since its inception about 3 years ago. That will fuel the rest of its preclinical stage of development as it looks to break into human studies in the back half of 2021.

That kind of 4-plus year timeline before the first human dosing could test the endurance level of a venture player. But Generation CEO Geoff McDonough looks over the past 2 years advancing a new lipid nanoparticle delivery system for their closed-end DNA therapies working to the day when gene therapies can be produced and sold for far less than the $2 million-or-so price tag today and sees lots of fast-paced advances.

I think the reality is we didnt have an expectation at the outset (on timelines), McDonough tells me. Recognizing the novel work needed to build the platform, the investors knew it would take time and money to bring them up to a GMP level.

I would say for a 40-year problem, adds the CEO, 2 years seems pretty good.

The founding tech at Generation was designed to do what AAV treatments do in the nucleus, offering enduring expression, while allowing manufacturing at a biologic scale with a more economical, capsid-free production method. Taking a page from the tech handbooks at companies like Alnylam and Moderna, theyre building a gene therapy that they believe can do much better than the fragile, one-time-only pioneers. And without the $1 million production cost that keeps wholesale prices in the low 7-figure range.

Theyre looking for much greater economy, eventually taking these therapies to much broader ailments and out of the realm of rare diseases with a new approach that they believe can be infinitely redosable on an as-needed basis.

Thats the big picture.

Generations team is working on 2 lead programs for hemophilia A and phenylketonuria (PKU) to go into IND-enabling studies. Theyve now identified Wilson disease and Gaucher disease as likely starting points for the next steps as they move past the liver to skeletal muscle and the retina and then other tissues. And McDonough the former CEO at Sobi is looking down the road 12 to 18 months when hed like to turn to the public markets with an IPO to fund the first clinical-stage work.

In the meantime, hed like to concentrate on opening another new chapter of the company on the dealmaking side.

It felt very important not to partner initially, says McDonough. The investors wanted to retain ownership of platform. We just had tremendous good fortune we didnt need to do that for finance reasons. But now that they have a better grasp of the technology and what needs to be done, its time to partner probably later in the year.

T. Rowe Price funds and accounts led the round, with Farallon and Wellington Management Company jumping in alongside. Existing investors Atlas Venture, Fidelity, Invus, Casdin, Deerfield, Foresite Capital and an entity associated with SVB Leerink came back to stay in the syndicate. Cowen served as exclusive placement agent for the offering.

Read more:
With $110M to add to the bankroll, Generation Bio sets its sights on engineering a revolution in the gene therapy field - Endpoints News

Read More...

Carolyn Cushman Reviews Laughter at the Academy by Seanan McGuire and Sorcery of Thorns by Margaret Rogerson – Locus Online

Saturday, January 11th, 2020

Seanan McGuire, Laughter at the Academy (Subterranean Press 978-1-59606-928-2, $40.00, 374pp, hc) October 2019. Cover by Carla Speed McNeil.

McGuires introduction calls this her first single-author short story collection, which isnt exactly true, but it is her first collection of non-series stories, 22 of them, all originally published from 2009-2017. The bulk of them are dark tales; she has a tendency to pick one creepy idea and then push it to extremes. Many of the story introductions include trigger warnings, ranging from unapologetic to outright boasting. Most symptomatic, perhaps, is The Tolling of Pavlovs Bells which Contains a remarkably high death toll, even for me, and detailed discussion of disease progression. The story, about a mad doctor determined to teach the world a lesson about not taking the risk of plagues seriously, is truly scary yet amusingly over-the-top germophobes and hypochondriacs beware. The title story also plays with mad science, though with a twist. McGuire likes twisting things like tropes, urban legends, and familiar stories; two look at the legend of Peter Pan, while one of my favorite stories, Emeralds to Emeralds, mixes elements of film noir and Oz, with Dorothy a bitter witch investigating a murder in an Oz where the arrival of too many visitors from Earth has caused the natives of Oz to turn against them. We Are All Misfit Toys is a near-future horror story of what happens when AI toys become too attached to their children. Plague and mad science, AI, genetic engineering, ghosts, Lovecraftian beingstheres a lot of variety here, and not a little humor, but the dark thread is what sticks with you. There are so many ways to envision the end; even a fish story, Threnody for Little Girl, With Tuna, At the End of the World, that had me tearing up. Just a little.

Margaret Rogerson, Sorcery of Thorns (McElderry 978-1-4814-9761-9, $17.99, 453pp, hc) June 2019. Cover by Charlie Bowater.

Libraries and books come alive in this young-adult fantasy about an orphan raised to protect books of spells from the demon-wielding sorcerers who would misuse them. Elisabeth Scrivener, an apprentice librarian in the Great Library of Summershall, dreams of becoming one of the magic-fighting wardens, but things start going wrong. The librarys Director is killed, and a grimoire gets loose and turns into an evil Malefict and has to be destroyed. Elisabeth, who managed to stop the Malefict, is accused of the crime, and carted off to the capital by the powerful sorcerer Nathaniel Thorn who, it turns out, is only 18, and not pure evil as Elisabeth had been raised to expect. Even his demon, Silas, turns out to be less terrifying than punctilious, at least most of the time. Someone is out to stop Elisabeth from telling the truth, and she ends up fighting for her life, facing a high society she doesnt understand, escaping an appalling hospital for disturbed females, and ultimately works to save the world from a sorcerer backed by an ancient conspiracy. With Nathaniels help, she ultimately succeeds, but at a cost. The fantastic battles and magical encounters are nearly non-stop, leavened by Elisabeth and Nathaniels rocky relationship, which is beset by all sorts of absurd misconceptions that both have to get past if they are to work together. The humor and touches of romance make a charming counterpoint to the grim magics they face. Add books that want to join in the fighting and libraries that can choose whom to help, statues that come alive, and otherworldly encounters, and its a wonderfully dramatic and colorfully weird fantasy with a special appeal for book lovers.

Carolyn F. Cushman, Senior Editor, has worked for Locus since 1985, the longest of any of the current staff, and handles our in-house books database, writes our New and Notable section, and does the monthly Books Received column. She is a graduate of Western Washington University with a degree in English. She published a fantasy novel, Witch and Wombat, in 1994.

This review and more like it in the November 2019 issue of Locus.

While you are here, please take a moment to support Locus with a one-time or recurring donation. We rely on reader donations to keep the magazine and site going, and would like to keep the site paywall free, but WE NEED YOUR FINANCIAL SUPPORT to continue quality coverage of the science fiction and fantasy field.

Visit link:
Carolyn Cushman Reviews Laughter at the Academy by Seanan McGuire and Sorcery of Thorns by Margaret Rogerson - Locus Online

Read More...

As the planet warms, unusual crops could become climate saviors if we’re willing to eat them – GreenBiz

Saturday, January 11th, 2020

This article originally appeared in Ensia.

In southern Israels stifling heat, rows of salicornia, commonly known as sea asparagus or sea beans, grow under translucent tarps, planted into ground more sand than soil, irrigated with saltwater. This environment would kill most plants, but these segmented succulents look beautiful green and healthy. In partnership with researchers at Ben Gurion University of the Negev, local farmers are exporting them to markets in nearby countries.

Sea beans taste like salty cucumber and grow wild in coastal areas around the globe. But in recent years researchers have begun to focus on them for agriculture, especially in dry coastal regions such as India, Israel, Turkey and the United Arab Emirates. These researchers efforts are defining what extremes the plant can withstand, its nutrient needs and how to get it to grow faster and with greater yield. As the planet warms and the seas rise, resilient crops such as sea beans might become climate saviors. But only if we are willing to eat them.

Everybody matters

Climate change is already affecting our food supply. In a paper published this year,researchers calculatedthat the available calories from the worlds top 10 food crops were 1 percent less annually than they would have been without the impact of climate change. Surveys show the potential for drought tops peoples climate concerns worldwide, but when it comes to growing crops, says Hope Michelson, an assistant professor of agriculture and consumer economics at University of Illinois at Urbana-Champaign, "its not just the amount of rain" that matters. Crops are also sensitive to variations in how quickly that rain falls, high and low temperature extremes, the frequency and intensity of storms and the length and timing of growing periods.

Food crops that can withstand such conditions will be increasingly important, and much discussion around climate-friendly food focuses on consumer choices and what they mean for broader adoption of these crops. Essentially, there has to be a market for climate-resilient foods to have a significant impact. Consumers can vote with purchasing dollars to support farmers who grow foods that will persist in difficult conditions, and those that require fewer resources.

But outside factors, the food and beverage industries among them, exert influence over our choices. While data on adults is mixed, research shows that food marketing strongly influences children. A 2009 article in the Annual Review of Public Health found evidence "that television food advertising increases childrens preferences for the foods advertised and their requests to parents for those foods." A more recent look at the data in The American Journal of Clinical Nutrition concluded, "Evidence to date shows that acute exposure to food advertising increases food intake in children but not in adults."

Essentially, there has to be a market for climate-resilient foods to have a significant impact. Consumers can vote with purchasing dollars.

Still, while most researchers recognize the importance of large-scale actions, such as those by large companies and government regulations, to influence the food system, many emphasize that individual food choices also can have an impact.

"You can most definitely make a movement with your pocketbook," says Samantha Mosier, an assistant professor in the political science department at East Carolina University. She points to trends in soda consumption, which has declined significantly in recent years. "Some of this has been brought on by the millennial generation trying to be healthier and to avoid some of the pitfalls of our older generation," Mosier says. Soda giants Coca-Cola and Pepsi areinvesting in lower sugar options such as kombucha, coconut water and sparkling water.

"When you think about land use and the predictions for climate change, much of it depends on consumer preferences," says Christine Foyer, a professor of plant sciences at University of Birmingham in the United Kingdom. "People decide what they eat, and economics drives the crops which drives the science. Everybody matters."

Climate-resilient plants

Environmentally sensitive eating often focuses on reducing meat consumption, and for good reason. "The environmental cost particularly of beef is enormous," Foyer says. Last year in the journal Science, researchers estimated that globally, "[m]oving from current diets to a diet that excludes animal products has transformative potential, reducing foods land use by (7.7 billion acres)" and greenhouse gas emissions by about 7.3 billion tons.

But plant-based choices matter too.

In the future, plants ability to withstand extreme conditions will become critical. Scientists are working to increase hardiness in todays staple crops such as wheat and corn through gene editing, genetic engineering and traditional breeding to increase the efficiency of photosynthesis, reduce water requirements and resist pests. In China, for example, researchers have used CRISPR to develop a strain of wheat that resists powdery mildew, a damaging fungal growth predicted to worsen with climate change. Meanwhile in India, the International Crops Research Institute for Semi-Arid Tropics (ICRISAT) developed early-maturing groundnuts to help farmers harvest before drought. Farmers who adopted these varietals earned an additional $119 per 2.5 acres, according to the organization.

Scientists are working to increase hardiness in todays staple crops such as wheat and corn ... to increase the efficiency of photosynthesis, reduce water requirements and resist pests.

Foyer also points to legumes and pulses which include fava beans, cowpeas, chickpeas and lentils because "they have their own nitrogen fertilization," reducing the need for fertilizers. Nitrogen-based fertilizers require energy to produce, can cause pollution and marine die-off when runoff enters streams and waterways, and may contribute to global warming as source of greenhouse gas emissions.

Yet another climate-friendly option is sea vegetables. Seaweeds such as kelp are farming powerhouses: high nutrition value; fast growing; and zero land use for growing. Not only that, but "when you grow kelp, youre growing it in ocean water and [the kelp is] absorbing carbon dioxide," Wheat says. "And when you suck up that carbon dioxide, you also change the pH and reduce the consequences of ocean acidification."

Changes require work

Not all climate-resilient foods are new and unusual. Okra, mushrooms, sweet potatoes and pomegranates are all resilient choices in many regions. So, too are edible "weeds"such as dandelion and burdock, which are hardy enough to survive our efforts to eliminate them. Yet as warming gets more extreme, researchers say we may have to adopt less familiar foods.

For many people, that wont be easy. What we eat has deep cultural significance, rich in memories and meaning. We cling to what we know, and changes require work. Then there are economic considerations, says Mosier. When people are concerned about the economy, food choices based on environmental impacts can take a back seat to simply putting enough food on the table.

Some recent examples point to how changing diets isnt impossible. Quinoa and the Impossible Burger, a plant-based burger masquerading as beef, are two recent success stories that at first seemed unlikely to win over U.S. consumers. The Chicago Tribune reported in 2016, "Americans consume more than half the global production of quinoa, which totaled [34,000 metric tons] in 2012. Twenty years earlier, production was merely [544 metric tons]." The Impossible Burger, although it makes up a small percentage of the U.S. meat market, is for sale in more than 15,000 restaurants in the United States, Hong Kong, Macau and Singapore. It has been so popular that the company experienced a production shortage last summer, soon after announcing a partnership with Burger King. Production has caught up with the surging demand, and diners can find Impossible meat at White Castle, Red Robin and a host of smaller restaurants, as well as at grocery stores.

These foods owe their rise in large part to marketing and lobbying dollars, but there are other ways to find success. Anastasia Bodnar, policy director of Biology Fortified, a nonprofit organization focusing on issues in agriculture and biotechnology, says that chefs and restaurants also can have an impact on how people think about food.

"If you can make it cool, make it sexy, make it something that people want to see, thats going to end up in the news, then that interest gets perked up and then the market goes along with it," Bodnar says. "You see all kinds of weird invasive fish on menus that have been rebranded with different names."

If you can make it cool, make it sexy, make it something that people want to see, thats going to end up in the news, then that interest gets perked up and then the market goes along with it.

Whether familiar or foreign, our food crops will need to feed an increasing number of people in an increasingly hostile environment in the future. While structural, top-down change may be necessary to shift the entire food system to one that will weather the effects of climate disruption, such changes can be influenced by individual choices.

Back in Israel, on farms in the dry and salty desert, sea beans grow green in seawater. In India, rows of millet persist through drought. And in the frigid but warming waters around Seattle, kelp forests undulate with the tides. Such foods reduce pressure for climate-unfriendly land use change and thrive in environments that make other plants shrivel. That is, they are suited for the future which means we, too, can be more resilient to change.

Editors note: Jenny Morbers travel and access to researchers at Israels Ben Gurion University of the Negev was paid for and provided by the Murray Fromson Journalism Fellowship.

See the article here:
As the planet warms, unusual crops could become climate saviors if we're willing to eat them - GreenBiz

Read More...

‘Rise of Skywalker’ theory: Kylo comic joyfully retcons Snoke’s big twist – Inverse

Saturday, January 11th, 2020

One of the more dramatic retcons that Star Wars: The Rise of Skywalker established was making Snoke a puppet of Palpatine all along. I have been every voice you have ever heard inside your head, Palpatine says early in the film, transitioning from his own voice to Snokes and then to Darth Vaders to really drive that point home. I made Snoke! Then we see a few Snoke clones growing in a vat, implying that the Supreme Leader was always just some kind of artificial humanoid alien created and used by Palpatine.

A new canon comic, however, complicates matters by trying to make Snoke even more of his own person. Has Star Wars become the war of the retcons? And which version of Snoke are we supposed to believe?

Star Wars: The Rise of Kylo Ren #2 was released Wednesday, and in it, we see more of Ben Solos visit to Snoke that began in the first issue. After he flees from the destruction of Luke Skywalkers Jedi academy, he heads straight to some small space station thats a floating greenhouse of sorts. There, Snoke admits that he was not born Snoke.

If he was not born Snoke, then who was he before? Were meant to see an obvious parallel between Darth Vader and Anakin Skywalker, between Ben Solo and Kylo Ren, the idea that to fully embrace the Dark side, a person has to cast aside their original identity and become something new.

This makes it seem like hes not just an empty vessel controlled by Palpatine, assuming hes telling the truth about being somebody other than Snoke at some point. Was he a sentient person that became Snoke when he embraced the Dark side, and then Palpatine took control over that body and cloned it? Or are we supposed to believe this is Palpatine saying these words through Snokes mouth and lying? Something doesnt quite add up here.

All this talk of names comes up when Ben Solo complains about the legacy of his own name. Theres Ben after Obi-Wan Kenobi, the fake name assumed by a famous Jedi he never even met, yet another reflection of the lofty expectations of his legacy. Then theres Solo, the fake surname assigned to his father by an Imperial soldier. To Ben Solo, both of his names feel like a lie.

Who will you become? Snoke asks Ben Solo. The way of the Dark side is to embrace this new identity, and The Rise of Kylo Ren is setting up an inevitable confrontation between Ben Solo and Ren, who at this point in time leads the Knights of Ren. Hes not around for the new trilogy, so Ben Solo will probably have to kill him by the end of this series and assume his name.

This isnt even the first time that The Rise of Kylo Ren writer Charles Soule has adjusted Snokes story in surprising ways. In The Rise of Kylo Ren #1, Ben Solo says, Snoke look what Master Luke did to you. Ben Solo has known Snoke for a long time, and Snokes scarring is due to some kind of attack from Luke. However, in The Rise of Skywalker, the Snoke clones on Exogol also have the scarring. Thats not how genetic engineering works.

Theres always the possibility that everything Snoke says in these comics is just Palpatine lying so he can manipulate Ben Solo, but these comic books seem like theyre overcomplicating Snokes identity in ways that are hard to grasp.

Star Wars: The Rise of Kylo Ren #3 will be released February 12, 2020.

Read the original here:
'Rise of Skywalker' theory: Kylo comic joyfully retcons Snoke's big twist - Inverse

Read More...

‘The good of the world partly depends on unhistoric acts’ – The Guardian

Saturday, January 11th, 2020

Welcome back and happy new year.

The turn of a decade is always a great time for taking stock, for predictions and forecasts about the new era to come. In case you missed it, the Upside published its review of the super-trends of 2010s over the Christmas period and asked readers what they thought the dominating tendencies of the 2020s would be.

There were some thought-provoking responses.

John Simke predicted that the 2020s would mark the end of seven decades of overenthusiastic consumerism:

By 2030, buying consumer goods will not only be looked down on, increasingly it will not be done, particularly in the rich world. This will go far beyond conscious consumption to complete cessation of consumption. This will be led by the younger generation but will be picked up by everyone. Our economy will shift from being consumption led to being savings and investment led, as we spend trillions of dollars on a new energy system and climate change adaptation. Obviously this will be driven by the need to mitigate climate change.

Kevin Fisher in Los Angeles forecast a series of ends. The end of work as we know it, the end of human contact, the end of disease:

I think even in the next decade we will see more and more diseases eradicated completely and as we start to treat illness with in-body genetic engineering we will see hereditary conditions also disappear.

Robbie Morrison in Berlin is buoyant about prospects for a more open society:

I predict open will become a supertrend: more specifically, open civil society organizations and open analysis in pursuit of solutions to our existential crisis of sustainability.

It was the opensource world that bequeathed the ethos, the community norms, the decision processes, the copyleft and permissive open licensing models, the versioning and issues tracking tools, the concept of predominantly online collaboration, and the web platforms in support.

So I see this fledgling supertrend in the raft of new selforganizing civil society communities confronting climate change, including Extinction Rebellion, GermanZero, Fridays for Future, and Scientists for Future.

To this end, Ive embarked on trying to build a community to analyze future zerocarbon energy systems thus, with some background here.

And finally, Tom Forster ran through an exotic list of predictions including skyrocketing pet ownership, drug liberalisation, the return of the city state, anti-fashion, nationalist art and my own favourite, ocean travel:

I think ocean/rail liners will start targeting #generationeasyjet, diversifying their onboard services to subcontract for millennial appetites such as rage rooms, food/beer markets, vegan cuisine, axe throwing, escape games, gin tastings, etc.

As for me, I predict a giddy torrent of optimistic journalism. Already in the last week or so, we have published:

US greenhouse gas emissions fell 2% in 2019, according to preliminary estimates, as cheaper natural gas supplanted coal at a prodigious rate.

Also falling in the US is the cancer death rate, by 2.2% in the latest year on record the biggest ever reported decline.

And it was a good week for auto workers in the US and bakers in the UK. Automakers GM and Ford made more than 1,500 temporary workers permanent members of staff under a new union deal. British baker Greggs gave its 25,000 staff a bonus of up to 300 each, as the company continued to thrive.

Vogue Italias startling decision to publish its January edition without any photos.

Also, various media reports detailing Australian generosity to raise money to battle the bushfires.

But most of all, we loved this NPR piece about the scary moms and crowdfunded activists pressuring the Pakistani government to do something about apocalyptic air pollution.

We had plenty of further suggestions for Upside Legends, following our article just before new year highlighting the unsung heroes who really deserve public acclamation.

Inka Wienbarg wrote:

Salma Zulfiqar started the Migration Project in 2016, she has been producing artwork and delivering her ARTconnects workshops to change perceptions in communities and promote cultural understanding and empower women, in particular vulnerable young women. Her passion and drive to create peaceful communities and have a positive impact has meant that hundreds of people have engaged in her ARTconnects workshops in the Midlands, Manchester, London, Norwich, Greece, the UAE, France and Italy that have all have benefited from her work at a critical time when racism and hate crimes are increasing.

Nicholas Hale nominated his sister, Rachel Bramwell:

Rachel is a reception and special needs teacher at Thatto Heath Community Primary School in St. Helens, Merseyside. Its quite a deprived area and my sister has taught at the Thatto Heath since she qualified as a teacher, 26 years ago. Come rain, shine or freezing snow, my sister is there for her class - day after day, week after week, year after year. I cant even begin to imagine how many childrens lives shes changed for the better.

My sister and I have always shared a love of literature. In her masterpiece, Middlemarch, the great novelist George Eliot writes: The growing good of the world is partly dependent on unhistoric acts; and that things are not so ill with you and me as they might have been, is half owing to the number who lived faithfully a hidden life.

In the British royal household, where the Duke and Duchess of Sussex showed the way towards a more streamlined monarchy.

Follow this link:
'The good of the world partly depends on unhistoric acts' - The Guardian

Read More...

Gene Therapies Make it to Clinical Trials – Discover Magazine

Wednesday, January 1st, 2020

After years of ethical debates and breakthroughs in the lab, CRISPR has finally made its way to clinical trials. Researchers are now looking at whether the DNA-editing tool, as well as more conventional gene therapies, can effectively treat a wide array of heritable disorders and even cancers.

Theres been a convergence of the science getting better, the manufacturing getting much better, and money being available for these kinds of studies, says Cynthia Dunbar, a senior investigator at the National Heart, Lung, and Blood Institute. Its truly come of age.

CRISPR formally known as CRISPR-Cas9 has been touted as an improvement over conventional gene therapy because of its potential precision. CRISPR (clustered regularly interspaced short palindromic repeats) is a genetic code that, contained in a strand of RNA and paired with the enzyme Cas9, acts like molecular scissors that can target and snip out specific genes. Add a template for a healthy gene, and CRISPRs cut can allow the cell to replace a defective gene with a healthy one.

In April, scientists at the University of Pennsylvania announced they had begun using CRISPR for cancer treatments. The first two patients one with multiple myeloma, the other with sarcoma had cells from their immune systems removed. Researchers used CRISPR to genetically edit the cells in the lab, and then returned them back into their bodies.

On the other side of the country, Mark Walters, a blood and bone marrow transplant specialist at the University of California, San Francisco, Benioff Childrens Hospital in Oakland, is gearing up for trials that will use CRISPR to repair the defective gene that causes sickle cell disease. With CRISPR, once youve made that type of correction, [that cell] is 100 percent healthy, says Walters.

Another team is tackling the same disease using a type of hemoglobin, a protein in red blood cells, thats normally made only in fetuses and newborn babies. Researchers found that some adults continue to produce these proteins throughout their lives, and when those adults also have sickle cell disease, their symptoms are mild. So the international team used CRISPR to disable the gene that interferes with production of this hemoglobin, resuming its production and protecting the adult patients against sickle cell disease.

Several other CRISPR studies are in the works to treat a range of inherited disorders, including hemophilia and SCID-X1 (also known as X-linked severe combined immunodeficiency, the so-called bubble boy disease in which babies are born without a functioning immune system).

At St. Jude Childrens Research Hospital, a gene therapy trial cured Gael Jesus Pino Alva (pictured with his mother, Giannina) of SCID-X1, the bubble boy disease. (Credit: St. Jude Children's Research Hospital/Peter Barta)

The past year also saw success in a handful of experiments on conventional gene therapy. Instead of using CRISPR to repair disease-causing genes, these treatments use hollowed-out viruses to ferry healthy versions of genes into cells. Millions of these altered cells are released into the bloodstream or bone marrow in hopes that enough will land in the right places. But because scientists cant predict where the circulating genes may end up, this shotgun approach has had unintended, sometimes fatal, consequences including, in an earlier study, inadvertently activating leukemia-causing genes in patients treated for SCID-X1.

But in 2019, researchers learned that using a different type of virus one related to HIV to transport the genes may prevent these side effects. In an April study, researchers at St. Jude Childrens Research Hospital in Memphis, Tennessee, and UCSF Benioff Childrens Hospital in Oakland collected bone marrow from eight newborns with SCID-X1. They loaded corrective genes into the disabled HIV-related virus, which carried them into the patients bone marrow stem cells. The infants also received low doses of busulfan, a chemotherapy that gave the doctored stem cells room to grow. So far, we havent seen anything worrisome, says Ewelina Mamcarz, a pediatric oncologist at St. Jude who led the research team. The study recently added its 12th patient.

Gene therapy does have its momentum [back], says Mamcarz, reflecting on the fields setback after the earlier studys leukemia side effects. Theres so much that still needs to be done, and so many questions, she says. [But] this is how medicine evolves. We always want to be better than we were a week ago.

In the future, the hope is that gene therapy technologies will move beyond mending simple genetic mistakes and be used to combat big killers like diabetes or heart disease. [Those diseases are] more challenging, but a lot of them would benefit from knocking out a bad gene, says Dunbar.

For now, though, researchers are optimistic about the progress thats already been made. All of this has been very encouraging, says Dunbar. [And] for sickle cell in the U.S. and hemophilia in the developed world, these diseases may soon be solved.

[This story originally appeared in print as "Gene Therapy Gets Clinical."]

Originally posted here:
Gene Therapies Make it to Clinical Trials - Discover Magazine

Read More...

Deficiency of TRPM2 leads to embryonic neurogenesis defects in hyperthermia – Science Advances

Wednesday, January 1st, 2020

INTRODUCTION

The cerebral cortex is the most evolved and complicated structure in the mammalian brain and has many physiological functions, such as attention, cognition, learning, and memory. The functions rely on the detailed cortex structure, which includes a six-layered architecture formed by migrating neurons in an inside-out pattern (1). These plentiful neurons are generated from various neural progenitor cells (NPCs). The primary progenitor cells are radial glial (RG) cells, which are mainly responsible for self-renewal and result in the expansion of the cortex, the differentiation of neurons, and the production of postmitotic neurons (2). The process of neuronal production, also known as neurogenesis, plays crucial roles in cerebral development and can affect the function of the neocortex. Generally, each process in neurogenesis, including self-renewal, differentiation, and the maturation of neurons, is strictly regulated, and any disturbance leads to severe disorders (3). The entire process is regulated by numerous extracellular and intracellular signals and factors. Any stress or unusual stimulus may lead to abnormalities in brain function.

During pregnancy, various stimuli can lead to abnormal neural development (4, 5). Among them, heat stress is an important stimulus for both the mother and fetus during pregnancy, and maternal thermal homeostasis is critical for fetal survival and ontogenesis. For example, maternal fever during the gestation period is associated with congenital heart defects and neural tube defects (6, 7). However, it is largely unknown whether heat stress, such as hyperthermia, disturbs neurogenesis and cortical development.

A series of thermally activated ion channels has been reported to detect the entire thermal range (8, 9). Among them, transient receptor potential channel M2 (TRPM2) is a plasma membrane calcium-permeable cation channel and is a unique member of the TRP family that is sensitive to various signals. Recently, studies have reported that TRPM2 can be activated by heat and that the deletion of TRPM2 in mice results in a remarkable deficit in their perception of nonpainful warm stimuli in the range of 33 to 38C (10). TRPM2 has been implicated in several neurodevelopmental/neurological disorders including bipolar disorder, neuropathic pain, and Parkinsons disease (11). In addition, TRPM2 has been shown to participate in various biological processes, including insulin secretion, H2O2-induced cell apoptosis, and brain damage following ischemic insults in adult and neonatal mice (1214). Therefore, it is crucial to investigate the precise functions and molecular mechanisms of the hyperthermia-related protein TRPM2 and characterize the proteins role in the regulation of brain development during heat stress and maternal hyperthermia.

Several pieces of evidence have demonstrated that canonical Wnt signaling, including -catenin, which acts as a core downstream effector, determines the transition from neuronal proliferation to differentiation during cortical neurogenesis. In the early stages of neurogenesis, the overexpression of -catenin in NPCs promotes their proliferation, whereas a deficiency in -catenin in NPCs facilitates neurogenesis (15). The precise signal transductions that modulate neurogenesis are unclear and need further elucidation. The transcription factor SP5 (specificity protein 5) is a member of the SP transcription factor family (16), and previous studies have shown that SP5 plays a crucial role in governing mouse embryonic stem cell pluripotency (17) and neural crest specification (18). During vertebrate development, SP5 acts downstream of Wnt/-catenin signaling in neuroectoderm patterning (19). In addition, the hypermethylation of SP5 has been implicated in schizophrenia, a neuropsychiatric disorder associated with the dysregulation of neural stem cell (NSC) proliferation and differentiation (20, 21). However, the role of SP5 in hyperthermia during neurogenesis has never been reported.

Here, we demonstrate that the thermo-sensor protein TRPM2 is enriched in the embryonic cerebral cortex and that its expression gradually increases during heat stress. We also show that TRPM2-deficient mice exposed to heat show reduced NSC proliferation and a premature shift in RG differentiation. Mechanistically, this study identifies an important role of TRPM2 in modulating SP5 expression by inhibiting the phosphorylation of -catenin in sustaining neural progenitor self-renewal during heat stress. In addition, the heat-induced proliferation defects caused by TRPM2 knockdown or knockout can be partially rescued by the overexpression of SP5. Collectively, these findings reveal that the heat sensor protein TRPM2 has a previously unidentified role in modulating cortical neurogenesis during hyperthermia conditions. These findings provide previously unknown insights to further elucidate neurological disorders associated with heat stress and reveal previously unidentified strategies for treatment.

To determine the effect of heat stress on the developing cortex, we performed stress experiments in which pregnant mice were placed in a thermostatic biochemical incubator (fig. S1A) set to 38C for 2 hours from embryonic day 13.5 (E13.5) to E15.5; the control group was kept at room temperature. After heat stress, E15.5 brain slices were stained with an antibody against mitotic index PH3. Compared with that in the control group, the number of PH3-positive cells residing at both the apical and basal positions was notably augmented, indicating that heat stress promoted mitotic activity (Fig. 1, A to C). Consistently, double staining for bromodeoxyuridine (BrdU) with PAX6 (one type of neural progenitor marker) (Fig. 1, D and E) and TBR2 (an intermediate progenitor marker) (Fig. 1, F and G) revealed that the number of cells in the proliferative state was increased in hyperthermia. Collectively, these results indicate that heat stress promotes neural progenitor self-renewal. In a second group of pregnant mice, similar heat stress was induced at E13.5 to E16.5; then, in utero electroporation (IUE) was performed to analyze embryonic brain development. When embryos were electroporated with a green fluorescent protein (GFP)encoding plasmid, which was used as a control plasmid on E13.5 and collected on E16.5, the hyperthermia group showed an abnormal distribution, which manifested as an increase in the number of cells in the ventricular zone/subventricular zone (VZ/SVZ) and a reduction in the number of GFP-positive cells in the cortical plate (CP) compared with those in the room temperature group (Fig. 1, H and I). In our research, the control mice were maintained in the vivarium at room temperature. We also conducted IUE experiments when mice were maintained in an incubator or in the vivarium at room temperature and found that the stress experienced by the mother due to moving to a new environment did not play a role in the observed phenotypes (fig. S1, B and C). Together, these results demonstrate that heat stress may disturb neurogenesis during embryonic brain development.

(A to C) E15.5 brain sections from the room temperature and hyperthermia groups were immunolabeled with the mitotic marker PH3 and 4,6-diamidino-2-phenylindole (DAPI). The graphs show the number of PH3+cells per 100 m2 at the apical and basal positions (n = 6). Scale bar, 20 m. (D to G) Mice underwent 2 hours of BrdU pulse labeling and were euthanized at E15.5. Brain slices were then double stained with antibodies against BrdU/PAX6 and BrdU/TBR2. The graphs show the populations of BrdU+PAX6+ and BrdU+TBR2+ cells relative to the total population of BrdU+ cells (n = 6). Scale bars, 20 m. (H and I) Thermal stimuli lead to the abnormal distribution of GFP-positive cells in the developing neocortex. An electroporation experiment was conducted at E13.5, and embryonic brains were collected on E16.5. The percentage of GFP-positive cells in each region is displayed in the bar graph (n = 6 embryos from four different mothers). Scale bar, 50 m. IZ, intermediate zone. (J) Reverse transcription polymerase chain reaction (RT-PCR) results showing the relative mRNA levels of members of the TRP family in the heat stress experiment (n = 3). n.s., not significant. (K) TRPM2 is abundantly enriched in NESTIN-positive NSCs in the embryonic cerebral cortex. E13.5 and E15.5 brain slices were immunostained with anti-NESTIN and anti-TRPM2 antibodies (VZ/SVZ) (n = 5). Scale bars, 20 m. (L) TRPM2 is expressed and colocalized with SOX2 and NESTIN in primary NSCs. The cells were collected from the cerebral cortex of E12.5 mouse brains and maintained in proliferative medium for 24 hours (n = 4). Scale bars, 20 m. (M and N) TRPM2 expression increases at warm temperatures in the E15.5 cerebral cortex. E15.5 brain sections were stained with an antibody against TRPM2. The graph shows the relative expression intensities of TRPM2 (n = 6). The intensity of TRPM2 was quantified with ImageJ. Scale bar, 20 m. The data are shown as means SEM; two-tailed Students t tests; *P < 0.05, **P < 0.01, and ***P < 0.001 versus the indicated group.

It has been reported that many receptors are thermally sensitive (10). To verify heat sensitivity, we housed pregnant mice with E13.5 fetuses at 38C for 2 hours for 3 days. Control pregnant mice were kept at room temperature. After 3 days (i.e., E15.5), RNA was extracted from the cerebral tissues of fetal mice. We detected the RNA levels of several receptors associated with heat (10, 22) and observed that in mice subjected to heat stress, the mRNA levels of only TRPM2, among the numbers of the TRP family, increased significantly (Fig. 1J). Molecular markers of heat-sensitive neurons within the preoptic hypothalamus were also affected. BDNF and PACAP mRNA levels increased (fig. S1D), which is consistent with previous studies (23). To examine the specific expression pattern of TRPM2 in the early embryonic brain, we conducted immunofluorescence and colocalization analyses. In vivo, the brain sections of E13.5 and E15.5 mice were collected and stained with antibodies against TRPM2 and the two neural progenitor markers, namely, NESTIN (24) and SOX2 (sex-determining region Yrelated HMG box 2). TRPM2 was observed to be colocalized with NESTIN-positive and SOX2-positive progenitor cells and resided in the VZ/SVZ of the cerebral cortex in both E13.5 and E15.5 brain sections from mice housed at room temperature (Fig. 1K and fig. S1E). In addition, in vitro, we observed that TRPM2 was coexpressed with NESTIN and SOX2 in primary mouse NSCs derived from E12.5 cerebral tissues and cultured in proliferation medium for 2 days (Fig. 1L). Next, to investigate TRPM2 expression at different developmental stages, we harvested cerebral tissues from E13.5, E15.5, and E18.5 and analyzed them using Western blotting. The results revealed that TRPM2 expression gradually increased from E13.5 to E18.5 (fig. S1, F and G). We also investigated TRPM2 transcription in vivo using cortical tissues and in vitro using NPCs cultured under differential or proliferative conditions. Reverse transcription polymerase chain reaction (RT-PCR) was performed on RNA extracted from the tissues or the NPCs. All data indicated that the mRNA levels of TRPM2 showed an obvious up-regulation as embryonic development proceeded (fig. S1, H to J). In addition, another group of pregnant mice was housed at 38C for 2 hours for 3 days at E15.5. Heat-treated mice showed a marked augmentation of TRPM2 expression in the VZ/SVZ of the neocortex compared with that in control mice (Fig. 1, M and N). Overall, these findings suggest that TRPM2, especially during heat stress, plays an important role in modulating NSC neurogenesis during embryonic cortical development.

On the basis of the distinctive expression pattern of TRPM2 in NSCs, we explored whether TRPM2 plays a unique role in neurogenesis during embryonic brain development. We generated a TRPM2-targeting short hairpin RNA (shRNA) plasmid and a TRPM2-overexpressing lentiviral-based vector to effectively silence and augment TRPM2 expression, respectively, in neural progenitors. In NPCs (Fig. 2, A and B, and fig. S1M), N2A cells (fig. S1, L and O), and 293FT cells (fig. S1N) treated with our constructs, Western blotting confirmed TRPM2 knockdown or overexpression. To verify our strategy, we further confirmed TRPM2 shRNA knockdown efficiency by real-time PCR analysis in NSCs, and the analysis showed that TRPM2 levels were effectively suppressed (fig. S1K). Next, we investigated whether TRPM2 disturbs cell distribution in vivo using IUE. In E13.5 mice, brains were injected and electroporated with the TRPM2 shRNA or control plasmid, and the mice were sacrificed at E16.5 for phenotypic analysis. We observed no obvious change in the distribution of GFP-positive cells across the cerebral cortex (fig. S2, A and B). However, the more interesting observation was that when maternal mice were placed in a 38C temperature-controlled incubator for 2 hours from E14.5 to E16.5, TRPM2 knockdown resulted in an obvious reduction in the number of GFP-positive cells in the VZ/SVZ and a corresponding increase in the number of GFP-positive cells in the CP (Fig. 2, C and D). When a 39C temperature-controlled incubator was used, similar results were obtained (fig. S2, C and D). To observe more long-term effects, we performed IUE at E13.5 to E17.5 and comparable GFP-positive cell distributions were observed (fig. S2, E and F). In addition, we also sought to determine whether the knockdown of TRPM2 has a possible effect on cell migration. IUE experiments are frequently used to monitor cell migration during embryonic cerebral development (2527). Then, we performed an E15.5-to-E19.5 IUE experiment in mice at room temperature and an E14.5-to-E18.5 IUE experiment in mice exposed to heat (fig. S2, G to I) and found that there was nearly no difference in GFP distribution from the VZ/SVZ to the CP between the control and TRPM2 knockdown groups. These results jointly eliminated the influence of TRPM2 depletion on cell migration. Thus, the data suggest that TRPM2 may take part in regulating neurogenesis during heat stress.

(A) Western blot analysis confirmed the knockdown (empty pSicoR shRNA was used as a control) of TRPM2 in cultured NSCs. -Actin was used as a control. (B) The graph shows that TRPM2 expression levels were effectively knocked down in primary NSCs by TRPM2-shRNA (n = 6). (C and D) TRPM2 knockdown alters the distribution of cells in the cerebral cortex during heat stress. A control or TRPM2 shRNA plasmids were microinjected and electroporated into the brains of E13.5 mice, and brains were collected on E16.5. During the process, the mice were exposed to 38C for 2 hours per day from E14.5 to E16.5. The GFP-positive cell populations in each region are displayed in the bar graph (n = 6 embryos from four different mothers). Scale bar, 50 m. (E and F) The number of TUJ1+GFP+ cells is augmented in TRPM2 shRNAtreated animals subjected to heat stress. Brain slices from E16.5 mice were stained with an antibody against TUJ1. The population of TUJ1+GFP+ cells relative to the total population of GFP+ cells is shown in the bar graph (n = 6 embryos from four different mothers). Scale bar, 50 m. (G and H) The number of MAP2+GFP+ cells is slightly increased in TRPM2 shRNAtreated animals in hyperthermia. E16.5 brain slices were stained with an anti-MAP2 antibody. The population of MAP2+GFP+ cells relative to the total population of GFP+ cells is shown in the bar graph (n = 6 embryos from four different mothers). Scale bar, 50 m. (I) Silencing TRPM2 induces NPC terminal mitosis during heat stress. A TRPM2 shRNA or control plasmid was injected and electroporated into E13.5 mouse brains. BrdU was gently injected 24 hours after electroporation at E14.5, and the electroporated brains of the embryos were collected for analysis at E18.5. Immunohistochemical analysis was performed using anti-BrdU and anti-CUX1 antibodies. During the process, the mice were exposed to 38C for 2 hours per day from E14.5 to E18.5. The arrowheads represent BrdU+/GFP+ cells, and the arrows represent GFP+BrdU+CUX1+ cells. Scale bar, 20 m. (J) Bar graph displaying the population of BrdU+GFP+ cells relative to the total number of GFP-positive cells in the CP (n = 6 embryos from four different mothers). (K) Quantification of the population of GFP+BrdU+CUX1+ cells relative to the population of GFP+BrdU+ cells (n = 6 embryos from four different mothers). The data are shown as means SEM; two-tailed Students t tests; *P < 0.05, **P < 0.01, and ***P < 0.001 versus the indicated group.

On the basis of the reduction in the number of GFP-positive cells in the VZ/SVZ, which enriches NPCs, we considered the possibility that TRPM2 plays a vital role in modulating NSC proliferation in hyperthermia. To address this possibility, we injected BrdU into pregnant mice 2 hours before the collection of electroporated embryonic brains. In TRPM2 knockdown mice, heat stress at E13.5 to E16.5 led to a marked reduction in the percentage of GFP+BrdU+ cells (fig. S3, A to C), the percentage of GFP+BrdU+PAX6+ cells (fig. S3, D and E), the expression of mitotic marker PH3 (fig. S3, F and G), and the expression of TBR2 (fig. S3, H and I) in NPCs residing in the VZ/SVZ.

Together, these results indicate that TRPM2 is vital for maintaining the NSC pool. To further explore whether a decrease in NPC proliferation leads to precocious cortical neurogenesis, we analyzed cell cycle exit. After electroporating control or TRPM2-shRNA plasmids into embryonic brains at E13.5, BrdU was injected 24 hours before the collection of electroporated brains from embryos on E15.5 and from E14.5 to E16.5. During the process, the pregnant mice were kept at 38C for 2 hours per day. Next, we stained brain slices with antibodies against BrdU and the proliferative marker KI67 to evaluate cells that precociously exit the cell cycle. We observed a substantial augmentation of the indicator of cell cycle exit in the TRPM2-silenced group that was subjected to heat stress, confirming that the elimination of TRPM2 facilitated cell cycle exit in response to hyperthermia (fig. S4, A to C).

To verify the possibility that TRPM2 knockdown NPCs that exit the cell cycle during heat stress may differentiate prematurely into neurons, we stained brain sections with an antibody against TUJ1 (-III-tubulin, a neuronal marker) to label neurons. Analysis revealed an obvious change in the percentage of TUJ1+/GFP+ cells in brain slices from TRPM2 knockdown mice subjected to heat stress (Fig. 2, E and F). We also observed a remarkable increase in the number of cells expressing the neuronal or upper layer markers MAP2+/GFP+ (Fig. 2, G and H), SATB2+/GFP+ (fig. S4, D and E), and CUX1+/GFP+ (fig. S4, F and G) and a decrease in the number of cells expressing CTIP2 (a marker of deep layer neurons)+/GFP+ (fig. S4, I and J) compared to those in control brain slices, suggesting an increase in the differentiation of NSCs. We also birthdated neurons using BrdU to investigate whether TRPM2 knockdown accelerates the terminal mitosis of premature neural progenitors in mice challenged with heat. As previously described (28), BrdU was injected into the abdominal cavity of pregnant mice 24 hours after the electroporation of E14.5 fetuses, and the electroporated brains of the embryos were collected for analyses at E18.5 (fig. S4H). Because BrdU labels dividing cells in the S phase (29), the label becomes diluted and gradually disappeared upon the self-renewal of NPCs. Only cells that differentiate into neurons within the CP layer during their final mitotic division are permanently labeled. By staining with an antibody against BrdU, we observed a marked increase in the number of BrdU+/GFP+ (Fig. 2, I and J) cells in the TRPM2 shRNAtreated brains compared with control shRNAtreated brains. When colocalized with the outer cortical layer marker CUX1, a significant change in the percentage of CUX1+GFP+BrdU+ cells relative to that of GFP+BrdU+ cells in the TRPM2 shRNAtreated group was observed. These results indicate that more BrdU-labeled NPCs differentiated into CUX1-positive neurons in the CP in the TRPM2 shRNAtreated group (Fig. 2K). Collectively, these findings effectively demonstrate that during heat stress, TRPM2 loss of function results in augmented terminal mitosis and enhanced cortical neuronal differentiation.

To verify the role of TRPM2 in neuron development under conditions of heat, we conducted an in vitro experiment using cultured primary NSCs. NPCs obtained from the E12.5 cerebral cortex were infected with either a control or TRPM2 shRNA plasmidpackaged lentivirus. After 24 hours, the cells were then incubated at 38C for 3 days in proliferative medium and finally stained with antibodies against TUJ1 and KI67. We observed an obvious increase in the number of GFP+TUJ1+ cells (fig. S5, A and B) and a marked decrease in the number of GFP+KI67 + cells (fig. S5, C and D) in TRPM2-deficient cells compared with control cells, supporting our in vivo findings. However, when NPCs were incubated at 37C for 3 days, we observed no obvious change in the percentage of GFP+TUJ1+ cells in the TRPM2-deficient cells (fig. S6, H and I).

To further investigate the effects of TRPM2 on NPC morphology during heat stress, we kept NSCs acquired from E12.5 brains in differentiation medium at 38C for 3 days. Using confocal imaging, we observed that compared with control NSCs, TRPM2 knockdown NSCs exhibited longer neurite outgrowth and increased branching after hyperthermia (fig. S5, H to J).

In addition, IUE was performed at E13.5, and the GFP-positive region of the brains from the embryo was collected and digested 2 days after electroporation at E15.5. During E14.5 to E15.5, the pregnant mothers were held at 38C for 2 hours per day. Embryonic GFP-positive brain cells were acquired using fluorescence-activated cell sorting and then cultured for 2 days in proliferative medium at 38C. Notably, TRPM2-silenced cells obtained from embryos whose mothers were heat-challenged showed prominent branching and longer neurite outgrowth compared with empty vectortreated cells (fig. S5, E to G). Jointly, these results suggest that TRPM2 can inhibit neuronal development during heat stress and is required for maintaining stem cell self-renewal.

In E13.5 mice electroporated with a TRPM2 overexpression vector, we observed a prominent increase in the number of GFP-positive cells residing in the VZ/SVZ and a corresponding decrease in the number of GFP-positive cells in the CP at E16.5 when pregnant mothers were subjected to heat stress for 2 hours from E14.5 to E16.5 (fig. S6, A and B). Compared to the normal expression of TRPM2, TRPM2 overexpression during heat stress also led to more BrdU-positive cells in the VZ/SVZ (fig. S6, C to E), supporting a role for TRPM2 in promoting NSC proliferation. In addition, TRPM2 overexpression was found to rescue abnormal NPC distribution caused by the depletion of TRPM2 in vivo (fig. S6, F and G), demonstrating that TRPM2 is required for the proliferation of NPCs during heat stress.

To further explore the phenotype of TRPM2 knockout mice, we generated mice using the CRISPR-Cas9 system through zygote microinjection. The coding sequence (CDS) of TRPM2 is located in exon 3, but not exon 1. After CRISPR editing, a termination codon was introduced near the start codon in the CDS (Fig. 3A). Genotyping PCR (Fig. 3B), Western blotting (fig. S7A), and real-time PCR (fig. S7B) were all performed to identify the knockout efficiency at the genome, protein, and RNA levels, respectively. We verified the knockout of TRPM2 in pregnant TRPM2 knockout mice exposed to hyperthermia at E14.5 to E16.5 by immunostaining E16.5 brain slices with an antibody against TRPM2 (fig. S7C). In addition, by immunostaining with an antibody against cleaved caspase-3, we observed that, in hyperthermia, there was no significant difference in the number of cleaved caspase-3+ cells per field between E16.5 TRPM2+/+ and TRPM2/ brain slices, suggesting that TRPM2 knockout had no effect on cell apoptosis under conditions of heat (fig. S7, D and E).

(A) Schematic diagram of the generation of TRPM2 knockout mice. (B) Genotyping of TRPM2+/+ and TRPM2/ mice. The results show that the PCR products of TRPM2+/+ and TRPM2/ were 1291 and 511 base pairs (bp), respectively. WT, wild type. (C and G) E16.5 brain slices from TRPM2+/+ and TRPM2/ mice were stained with DAPI and an antibody against PH3. Heat stress was applied from E14.5 to E16.5. The graph shows the number of PH3-positive cells per 100 m2 in the VZ/SVZ (n = 6). Scale bar, 20 m. (D and H) TRPM2+/+ and TRPM2/ mice underwent 2 hours of BrdU pulse labeling and were sacrificed at E16.5. Brain slices were then stained with antibodies against BrdU and PAX6. The graph shows the number of BrdU+PAX6+ cells per 100 m2 in the VZ/SVZ (n = 6). Scale bar, 20 m. (E and I) Coronal brain slices of E16.5 TRPM2+/+ and TRPM2/ mice were immunostained with an anti-CUX1 antibody. The number of CUX1+ cells per 100 m2 of CP is shown (n = 6). Scale bar, 20 m. (F and J) Representative images of E16.5 cortices showing SATB2-labeled cells. The graph shows the thickness of SATB2+ cells in the upper layer of the CP (n = 6). Scale bar, 20 m. (K) Deletion of TRPM2 leads to abnormal cell distribution and neurogenesis defects during heat stress. Furthermore, these defects were rescued by the constitutive expression of TRPM2 in the developing brain. A GFP-expressing control vector or TRPM2 overexpression vector was microinjected and electroporated into E13.5 mouse brains. Heat stress was administered from E14.5 to E16.5 for 2 hours a day. The brains were collected on E16.5 and stained for TUJ1. (L) The population of GFP-positive cells in each region is displayed in the bar graph (n = 6 embryos from four different mothers). Scale bar, 50 m. (M) The population of TUJ1+ GFP+ cells among GFP+ cells is displayed in the bar graph (n = 6 embryos from four different mothers). Scale bar, 50 m. The data are shown as means SEM; two-tailed Students t tests; *P < 0.05, **P < 0.01, and ***P < 0.001 versus the indicated group.

Next, we obtained E16.5 TRPM2+/+ or TRPM2/ embryonic brains from mothers that had been housed at 38C for 2 hours per day from E14.5 to E16.5. By staining analysis, we observed fewer neural progenitors expressing PH3 (Fig. 3, C and G) and BrdU/PAX6 (Fig. 3, D and H) in the VZ/SVZ and more neurons expressing CUX1 (Fig. 3, E and I) and SATB2 (Fig. 3, F and J) in the CP in TRPM2 knockout brain slices. In addition, when immunostaining for TRPM2 together with NESTIN or TUJ1 was performed on E16.5, we found that the expression of NESTIN was decreased, while the level of TUJ1 was observably augmented after the deletion of TRPM2 in hyperthermia (fig. S7, F and G). Consistently, when mice were housed at 38C for 2 hours per day from E14.5 to E18.5, more neurons expressing CUX1 were observed in the CP in TRPM2 knockout brain slices both on postnatal day 0 (P0) and P6 (fig. S8, F to I), which suggests that the heat-mediated shift in the proliferation to differentiation ratio upon TRPM2 knockout has a consistent and longer-term effect in later stages of development. However, in brain slices obtained from embryos of mothers who had been housed at room temperature, we did not find an obvious difference in TUJ1 staining at P0 between the wild-type and TRPM2 knockout groups (fig. S8J). Consistently, progenitors isolated from hyperthermic E12.5 TRPM2/ embryos developed longer neurites and more branching after culture in differentiation medium for 3 days than those of hyperthermic E12.5 TRPM2+/+embryos, while room temperature embryos lacked these phenotypes (fig. S8, A to E). These observations suggest that TRPM2 knockout and hyperthermia accelerate neuron development. In addition, NSCs obtained from E12.5 TRPM2/ embryos formed smaller neurospheres than those of controls in hyperthermia, but not room temperature conditions, suggesting that the loss of TRPM2 inhibits NPC proliferation during hyperthermia (fig. S7, K to M). To validate the function of TRPM2 during cortical neurogenesis in times of hyperthermia, we electroporated the brains of fetal TRPM2+/+ and TRPM2 / mice with control plasmids and brains of fetal TRPM2 / mice with TRPM2 overexpression plasmids on E13.5. Then, on E16.5, we collected brain samples from mice that had been exposed to heat stress for 2 hours from E14.5 to E16.5. By staining with an anti-TUJ1 antibody, we found that TRPM2/ mice not only exhibited an aberrant distribution of GFP-positive cells in three cortical layers but also showed a prominent increase in the proportion of GFP and TUJ1double positive cells compared with that in TRPM2+/+ mice, which is reminiscent of TRPM2 knockdown mice subjected to heat stress. Moreover, forced expression of TRPM2 in TRPM2/ mice in hyperthermia could rescue the abnormalities evoked by the ablation of TRPM2, i.e., both the distribution and ratio of GFP+ TUJ1+ cells (Fig. 3, K to M). In addition, we also compared the distribution and ratio of GFP+ TUJ1+ cells between TRPM2/ mice at room temperature and TRPM2/ mice in hyperthermia groups. The results revealed that, upon exposure to hyperthermia, TRPM2/ mice displayed a significant increase in the number of GFP-positive cells in the CP and the percentage of TUJ1+GFP+ cells (fig. S7, H to J). These findings demonstrate the vital role of TRPM2 during embryonic neurogenesis. In addition, the consistent phenotype of TRPM2 knockout excludes the possibility of potential off-target effects of TRPM2 shRNA in knockdown experiments. To investigate the effect of TRPM2 deficiency on differentiating neurons in hyperthermia, we conducted an in vitro experiment using cultured primary neurons. The neurons were isolated from P0 hyperthermic TRPM2+/+ and TRPM2/ embryos and cultured in differentiation medium for 3 days. By staining with an antibody against TUJ1, we observed no obvious difference between the wild-type and TRPM2 knockout groups in terms of neurite length or number of branches (fig. S8, K to M), suggesting that TRPM2 deficiency induces no phenotype in neurons under heat stress. We also analyzed other stimuli, such as treatment with NaCl (fig. S8, N and Q), change in pH (fig. S8, O and R), and X radiation exposure (fig. S8, P and S), and subsequently found that TRPM2 was not activated by these stimuli. Overall, these findings indicate that well-regulated embryonic cortical development can be disturbed in hyperthermic conditions when TRPM2 is deleted.

To further detail how TRPM2 affects the developing brain in hyperthermia, we sequenced RNA (RNA-seq) to analyze transcriptome-wide changes that arise from the loss of TRPM2. Total RNA was acquired from the cortical tissue of E16 TRPM2 knockout and wild-type mice with mothers that were housed at 38C for 2 hours per day from E14.5 to E16.5. Sequencing was repeated twice for each sample to increase the reliability of the sequencing results. Gene Ontology (GO) analysis revealed that down-regulated genes were associated with cell proliferation and temperature stimuli, including the canonical Wnt signaling pathway, neuronal stem cell division, the detection of temperature stimuli involved in sensory perception, and the negative regulation of cell differentiation. The up-regulated genes were associated with neurogenesis, the regulation of neuronal development, and cell fate commitment (fig. S9A). These data jointly suggest a crucial role for the thermal sensor protein TRPM2 in cortical neurogenesis during hyperthermia. Next, we explored how the deletion of TRPM2 affects neurogenesis at the molecular level during heat stress. Among the differentially expressed genes identified by genome analyses, we selected genes that changed consistently in both sequencing results and finally selected SP5 as a downstream target (fig. S9B and Fig. 4A). To confirm the results of RNA-seq, we performed RT-PCR (fig. S9C) and Western blotting (fig. S9D) and observed that SP5 expression was significantly decreased in samples obtained from the cortex of TRPM2 knockout mice that had experienced heat stress. SP5 is a transcription factor that is downstream of Wnt signaling (17, 19), but the function of SP5 in cortical neurogenesis during hyperthermia has not yet been identified.

(A) The volcano plot indicates differentially expressed genes. The red dots represent up-regulated genes, while the green dots represent down-regulated genes. SP5 is one of the notably down-regulated genes. (B and C) SP5 knockdown results in an abnormal cellular distribution during heat stress. The bar graph shows the population of GFP+ cells in the CP, IZ, and VZ/SVZ (n = 6 embryos from four different mothers). Scale bar, 50 m. (D) Western blot results showing the change in the expression of TRPM2, total -catenin, phosphorylated -catenin, SP5, TUJ1, PH3, and PCNA during heat stress in TRPM2 knockout embryos. Heat stress was applied from E14.5 to E16.5 for 2 hours per day. -Actin was used as the control (n = 3). (E) TRPM2 knockout in vivo during hyperthermia increases GSK3 activity (n = 3). (F) The suppression of TRPM2 in NSCs during heat stress intensifies GSK3 activity (n = 3). (G) Calmodulin (CAM) interacts with GSK3 in hyperthermia (n = 3). (H) Western blot analysis showing changes in the expression levels of TRPM2, total -catenin, phosphorylated -catenin, and SP5 between the brains of room temperature and hyperthermia-exposed embryonic mice. -Actin was used as the loading control (n = 3). (I and J) The intracellular calcium ion concentration increases upon exposure to 38C. After neural stem cells were isolated from the E12.5 cortex cultured at 37C or 38C overnight, they were incubated for 30 min with Fluo-3, and the intracellular calcium fluorescence was quantified with a confocal LSM780 microscope. The graph shows the relative Fluo-3 intensity (n = 30). Scale bar, 15 m. (K) Calcium concentration reduction is caused by TRPM2 knockdown in hyperthermia. NSCs isolated from the E12.5 cortex were infected with a control or TRPM2-shRNA plasmid (red)packaged lentivirus. After 6 hours, the cells were cultured at 38C overnight; then, the calcium concentration was measured (n = 3). Scale bar, 5 m. (L) Western blots showing the expression levels of Flag, total -catenin, and phosphorylated -catenin in primary NSCs with constitutively expressing CAM in hyperthermia conditions. -Actin was used as a control (n = 3). The data are shown as means SEM; two-tailed Students t tests; ***P < 0.001 versus the indicated group.

To investigate the function of SP5 in embryonic brain development, we first stained brain slices with a specific fluorescent antibody against SP5. The in vitro results showed that SP5 was expressed in the nuclei of primary mouse NSCs and was colocalized with progenitor markers, such as NESTIN and SOX2 (fig. S9G). Consistently, SP5 was expressed in vivo in NESTIN-positive NSCs in the VZ/SVZ of the E13.5 cortex (fig. S9H). Furthermore, shRNAs targeting SP5 were constructed, and they effectively silenced the expression of SP5 (fig. S10A). In addition, samples from heat stressexposed mice in which the expression of SP5 was silenced showed an increased number of GFP-positive cells in the CP and a decreased number of GFP-positive cells located in the VZ/SVZ (Fig. 4, B and C). However, the redistribution of GFP-positive cells was not obvious in control mice from mothers that had been housed at room temperature (fig. S10, F and G). Immunostaining for KI67 also showed that fewer GFP+KI67+ cells were observed in the VZ/SVZ in SP5 knockdown mice that had been exposed to heat stress (fig. S10, B and C). In addition, we also found that the percentage of TUJ1-positive cells was obviously increased in neural progenitors that had been infected with an SP5 shRNApackaged lentivirus and had been exposed to hyperthermia (fig. S10, D and E). Overall, these data confirm that SP5 acts downstream of TRPM2 to modulate neurogenesis during heat stress.

To further confirm and elucidate the specific mechanisms by which TRPM2 exerts its effect on NPC proliferation in hyperthermia, we monitored the relative mRNA levels of SP5 and several molecular markers associated with proliferation. Transcription analysis revealed that -catenin mRNA levels were reduced by 40% in TRPM2 knockout NPCs from mice exposed to hyperthermia, while the levels of REST, Hes5, SOX2, CyclinD1, Foxg1, and Olig2 were unchanged (fig. S9C). These findings suggest that -catenin may work together with TRPM2 to regulate embryonic neurogenesis during heat stress. To compare the transcription results to translational outcome, we conducted Western blot analysis. Protein was obtained from E16 cortical tissue from TRPM2 knockout and wild-type mice that were housed at 38C for 2 hours per day from E14.5 to E16.5. Western blot analysis showed an obvious reduction in SP5 and -catenin expression levels. We also found that the phosphorylation levels of -catenin were augmented in TRPM2 knockout mice exposed to hyperthermia. In addition, decreases in expression of the proliferative markers PH3 and PCNA (proliferating cell nuclear antigen) and an increase in the expression of the neuronal marker TUJ1 in TRPM2 knockout mice clarified the role of TRPM2 in embryonic neurogenesis in hyperthermia (Fig. 4D). We obtained similar results in TRPM2 knockdown or TRPM2 overexpression primary NSCs exposed to 38C (fig. S9, E and F). In TRPM2 knockdown NPCs, immunostaining for total -catenin verified that its expression was reduced during heat stress (fig. S10, H and I). We did not observe such an obvious change under room temperature conditions (fig. S6J). Intrigued by the altered phosphorylation levels of -catenin in TRPM2 knockout mice exposed to hyperthermia, we tested the activity of glycogen synthase kinase 3 (GSK3), which is a serine/threonine kinase associated with -catenin phosphorylation. On the basis of the fact that GSK3 activity requires the autophosphorylation of Tyr216 (30), we evaluated protein levels and protein modifications. In TRPM2 knockout mice exposed to hyperthermia, we observed an obvious increase in Tyr216 phosphorylation, suggesting that TRPM2 may negatively regulate GSK3 activity (Fig. 4, E and F). The constitutive overexpression of TRPM2 during hyperthermia intensifies GSK3 activity (fig. S10K). In addition, Western blot analysis showed an increase in the expression of TRPM2, total -catenin, and SP5 and a decrease in the phosphorylation of -catenin (Fig. 4H). Together, these findings suggest that TRPM2 may modulate SP5 transcription by inhibiting the phosphorylation of -catenin and activating -catenin expression.

Intracellular calcium signaling plays key roles in neural development, including neuronal plasticity, neuronal survival, and neurogenesis (31). Studies have shown that intracellular calcium affects the -catenin pathway (32). To further investigate the mechanisms by which TRPM2 plays a role in activating -catenin expression, we measured the calcium ion concentration in NSCs using a confocal microscope and a calcium-sensitive dye. We observed that, when the cells were cultured at 38C overnight, the intracellular calcium levels were significantly increased (Fig. 4, I and J). However, when cells were transfected with the TRPM2-sh1 plasmid with red fluorescent protein (RFP), intracellular calcium decreased (Fig. 4K), suggesting that TRPM2 modulates intracellular calcium. Calmodulin (CAM) is a target of calcium ions within the cell, and once bound to calcium ions, CAM is activated and serves as part of the calcium signal transduction pathway by modulating interactions with various target proteins (33). In our study, we found that CAM interacted with GSK3 (Fig. 4G), and Western blotting showed that phosphorylated -catenin levels were reduced, while total -catenin expression was slightly increased when CAM was overexpressed during heat stress (Fig. 4L). Therefore, these findings suggest that thermal stimuli activate TRPM2, which increases intracellular calcium. Calcium ions can then bind to CAM, thus inhibiting the levels of phosphorylated -catenin and simultaneously activating the expression of -catenin.

On the basis of these results, we suggest that -catenin may enter the nucleus, bind to the SP5 promoter, and modulate the expression level of SP5 during heat stress. To test this hypothesis, we used a luciferase plasmid containing 2 kb of the SP5 promoter and measured luciferase activity (Fig. 5A). We also generated a vector that overexpressed -catenin with a hemagglutinin (HA) tag and characterized its efficiency by Western blotting (fig. S10J). At 39C, we observed more than twofold increase in luciferase activity in cells treated with the -catenin vector compared with cells treated with the empty vector, demonstrating that -catenin binds to the SP5 promoter to exert its function (Fig. 5A). To further determine the specific binding site, we used a chromatin immunoprecipitation (ChIP) assay (Fig. 5B). At 39C, in cells in which -catenin was constitutively expressed, the binding of -catenin 0.5 kb from the SP5 promoter increased, and binding decreased as the distance to the transcription start site increased (Fig. 5B). These differences were not observed at 37C (Fig. 5B). In addition, we analyzed the promoters of other -catenin target genes, such as Axin2 and CyclinD1, in hyperthermia and observed that there was almost no binding of -catenin (fig. S10, L and M), suggesting specificity for SP5.

(A) Flow chart of the luciferase assay in which the SP5 promoter was cloned into the psiCHECK-2 vector. (A) 293FT cells were transfected with an empty vector or a -cateninexpressing vector. Both groups were cotransfected with an SP5 promotercontaining psiCHECK-2 vector and cultured at 39C. After 36 hours of transfection, the relative luciferase activity was quantified and is shown in the bar graph (n = 4). (B) Four pairs of primers were designed for 0.5, 1, and 2 kb from the SP5 transcription start sites and SP5 CDS for ChIP analysis. (B) NPCs cultured in vitro at 39C were infected with a -cateninHAcontaining lentivirus and then pulled down using immunoglobulin G (IgG) or HA-incubated magnetic beads. The relative amount of SP5 promoter was detected via ChIP and real-time PCR and is shown in the bar graph (n = 3). (B) NPCs cultured in vitro at 37C were infected with a -cateninHAcontaining lentivirus and then pulled down with IgG- or HA-incubated magnetic beads. The relative amount of SP5 promoter was determined by ChIP and real-time PCR and is shown in the bar graph (n = 3). (C to F) SP5 overexpression rescues the cortical neurogenesis defects evoked by TRPM2 knockdown (C and D) or knockout (E and F) in hyperthermia. After electroporation (E13.5) and heat stress (E14.5 to E16.5), E16.5 brain slices were stained with anti-TUJ1 antibody. The bar graphs show the percentage of TUJ1+GFP+ cells relative to the total number of GFP+ cells (n = 6 embryos from four different mothers). Scale bars, 50 m. (G) Working model of TRPM2 function in modulating cortical neurogenesis during heat stress. TRPM2 during heat stress increases calcium influx, which inhibits the phosphorylation of -catenin and induces -catenin enrichment on the SP5 promoter, thereby promoting NPC proliferation. The data are shown as means SEM; two-tailed Students t tests; *P < 0.05, **P < 0.01, and ***P < 0.001 versus the indicated group.

To decipher the connection between TRPM2 and SP5 in neurogenesis during heat stress, we performed rescue experiments. We observed that the constitutive expression of SP5 increased the cell populations residing in the VZ/SVZ and ameliorated the irregularity of both the distribution and percentage of GFP+ TUJ1+ cells caused by TRPM2 knockdown (Fig. 5, C and D) and knockout (Fig. 5, E and F) during heat stress in vivo. Therefore, these data demonstrate that SP5 acts downstream of TRPM2 to modulate early cortical development in hyperthermia. Together, our data supported the notion that, during heat stress, TRPM2 increases SP5 levels via the stabilization of -catenin enrichment on the SP5 promoter, thus enhancing NPC proliferation (Fig. 5G).

Cortical neurogenesis is a very sophisticated process that is strictly controlled by a great deal of signaling molecules. If any step of this process goes wrong, abnormal brain functions, and thus neurodevelopmental disorders, result (34). Temperature homeostasis is essential for embryo survival, and heat stress disturbs numerous aspects of fetal development and brain function (35). TRPM2, which has been recently identified as a heat activation protein, plays an important role in the heat response. TRPM2 is also a calcium-permeable channel in the plasma membrane, and a growing body of evidence has shown that calcium signaling heavily affects neural progenitor proliferation during embryonic neurogenesis (10, 36). However, no details as to whether or how TRPM2 affects brain neural development under conditions of heat exist. Here, we used TRPM2 shRNA and knockout mice to investigate the specific functions of TRPM2 in NPC proliferation and differentiation, cortical neuronal morphology, and the mechanisms guiding embryonic neurogenesis under hyperthermic conditions.

In our study, we first confirmed the thermal sensitivity of TRPM2 and then observed that TRPM2 is expressed in NSCs. When expressed during heat stress, TRPM2 augments NPCs in the E15.5 cerebral cortex, providing clues regarding its effect on neurogenesis during hyperthermia. Furthermore, we found that heat stress changes cellular distribution and facilitates NSC proliferation. Previous studies have shown that at room temperature, TRPM2 loss of function leads to increased axonal growth to promote neuronal differentiation (37). Here, we demonstrated that TRPM2 can exert its function earlier, specifically at E13.5, and that during heat stress, the loss of TRPM2 has a more powerful effect on facilitating cortical neurogenesis. However, at room temperature, the phenotype is not obvious. Our data indicate that TRPM2 deficiency in hyperthermia results in a change in cell distribution and proliferation defects with a sharp drop in the NSC pool. We also found that the depletion of TRPM2 during heat stress increases cell cycle exit and premature cell terminal mitosis, ultimately promoting neurons to a more differentiated state. Both proliferation defects and abnormalities in neuronal morphogenesis lead to severe brain illness, such as autism and schizophrenia (38, 39). In addition, we were able to eliminate the influence of cell migration and apoptosis during hyperthermia by knocking out TRPM2. However, why the TRPM2 knockdown phenotype observed during heat stress is more obvious than the phenotype observed under room temperature conditions still needs to be explored.

To investigate the mechanisms underlying the unique phenotype caused by the loss of TRPM2 and hyperthermia, we searched for downstream targets using RNA-seq analysis and found that SP5 expression was decreased upon TRPM2 knockout and hyperthermia. SP5 is a member of the SP1 family of transcription factors, but its function in embryonic brain development is still unclear.

Our research shows that SP5 is abundant in NPCs and that, under conditions of heat, TRPM2 deficiency inhibits SP5 expression from E13.5 to E16.5. This leads to a decrease in the number of GFP-positive cells residing in the VZ/SVZ and results in the promotion of neuronal differentiation. To further decipher how TRPM2 enhances SP5 expression in hyperthermia, we analyzed some signaling molecules and found that total -catenin expression was significantly down-regulated, while the phosphorylation of -catenin was obviously increased upon TRPM2 deficiency and heat stress. -Catenin, which functions in canonical Wnt signaling, is abundant in NSCs and contributes to the modulation of NSC expansion (15). However, specific mechanisms of the protein are not entirely clear. Previous studies have indicated that Wnt/-catenin is associated with intracellular Ca+ (32). Given that TRPM2 is a calcium-permeable channel, we investigated calcium ions during heat stress, and our data showed a decrease in intracellular Ca+ levels upon TRPM2 knockout. Moreover, the overexpression of CAM inhibited the phosphorylation of -catenin and augmented the expression of -catenin. Using a luciferase and ChIP assay, we also confirmed that -catenin binds to the SP5 promoter during heat stress. Unexpectedly, our results indicated that the overexpression of SP5 ameliorates the defects evoked by TRPM2 loss of function in hyperthermia. However, in the future, the current hyperthermia model needs to be further improved because in human, such as fever response, immune system component may take part in this model.

In summary, our findings uncovered a novel mechanism by which TRPM2, a thermo-sensor protein, governs embryonic neural development during heat stress. Furthermore, the neuronal morphology abnormalities in TRPM2 knockout mice exposed to hyperthermia during embryonic development may provide novel insights into neurological disorders associated with heat stress, including maternal fever, and reveal new strategies for treatment. In terms of the mechanism, we found that when TRPM2 is activated by heat and intracellular calcium binds to CAM, the phosphorylation of -catenin is inhibited. Accumulating -catenin then binds to the SP5 promoter to ultimately enhance NPC proliferation.

Pregnant ICR mice were obtained from Vital River Laboratories. All animal-related experiments were conducted in line with the Animal Care and Use Committee of Institute of Zoology, Chinese Academy of Sciences. TRPM2 knockout mice used in our experiments were generated and kept in the Experiment Animal Center of Institute of Zoology, Chinese Academy of Sciences.

To construct shRNA-expressing plasmids, the oligonucleotides were inserted into the pSicoR-GFP (Addgene, 12093) or pSicoR-TOMATO lentiviral vector. The sequences of shRNAs targeting TRPM2 were as follows: TRPM2-sh1, AACCTTAGCTCATGGATTC (13); TRPM2-sh2, GACCTTCTCATTTGGGCCGTT (Sigma). The sequences of SP5 shRNAs were as follows: SP5-sh1, GGATTCAAAGGATTTGCTTTC (17); SP5-sh2, CCCGTCGGACTTTGCACAG (Sigma). The full-length complementary DNAs (cDNAs) of mouse TRPM2, SP5, and CAM were obtained via PCR and cloned into the Flag-tagged pCDH (System Biosciences, CD511B-1) vector for lentivirus packaging.

Human 293FT cells and mouse N2A cells were cultured in Dulbeccos modified Eagles medium (DMEM) that contained 1% penicillin-streptomycin (PS) and 10% fetal bovine serum (FBS). Mouse cortical NPCs from E12.5 mouse cortex were maintained in proliferation medium, which contained 50% DMEM/F12 (Invitrogen), 50% neural basal medium (Invitrogen), epidermal growth factor (EGF) (10 ng/ml), basic fibroblast growth factor (bFGF) (10 ng/ml) (Invitrogen), 1% PS, and 2% B27 (without vitamin A).

The production of lentivirus was obtained by transfecting the core and packaging plasmids into 293FT cells using GenEscort I (Nanjing Wisegen Biotechnology). The virus was gathered at 24, 48, and 72 hours after changing the medium 6 hours after transfection. The primary NSCs for Western blot and immunofluorescence were seeded in 6- or 24-well plates, which were coated with laminin (Invitrogen) and poly-d-lysine (Sigma) (both 10 g/ml) in advance. Twenty-four hours later, half of the medium was changed with proliferation medium without PS. Lentivirus was then added to each well and maintained for 8 hours. Meanwhile, to improve the infection efficiency, polybrene (2 g/ml) was mixed into the medium. Forty-eight hours later, to induce a differentiation state, the medium was displaced with low-glucose DMEM (Gibco) supplemented with 1% FBS (Invitrogen), 1% PS, and 2% B27 (with vitamin A).

IUE was performed as reported previously (40). In brief, pregnant ICR or C57 mice were deeply anesthetized with pentobarbital sodium (70 mg/kg). Subsequently, the recombinant knockdown or overexpression plasmids with a final concentration of 1500 ng/l were mixed with an enhanced GFP plasmid at a ratio of 3:1. In addition, 0.02% Fast Green was included as a tracer. Then, the mixture was microinjected into the lateral ventricle of the embryonic mouse brains using glass capillaries. Five electric pulses of 40 V (950-ms interval; 50-ms duration) were generated using an electroporator (Manual BTX ECM 830) and platinum electrodes. After IUE, the brains of the embryos were collected at E16.5, E17.5, or P1 for further phenotype analysis.

For neural progenitor proliferation analysis, BrdU (50 mg/kg) was injected 2 hours before brain harvesting at E16.5. For neuronal birth dating, BrdU (50 mg/kg) was administrated to pregnant mice at E14.5. For cell cycle exit analysis, BrdU (100 mg/kg) was administrated to pregnant mice 24 hours before brain collection at E15.5.

For heat stress experiments, mice were maintained in their cages, and the cages were put in a large temperature-controlled incubator set at 38 or 39C for 2 hours each day for 2 or 3 days.

Brain slices or cells cultured in vitro were washed with phosphate-buffered saline (PBS) for 5 min, fixed in 4% paraformaldehyde for 20 min, and blocked in 5% bovine serum albumin (Sangon)/PBS containing 1% Triton X-100 (1% PBST) for 1 hour. Subsequently, the primary antibody was diluted with 1% PBST, added, and then incubated at 4C overnight. The following day, the samples to be visualized were rinsed with PBS three times and incubated with secondary antibodies at room temperature for nearly 1.5 hours. The primary antibodies used for immunofluorescence are listed here: rabbit anti-TRPM2 (1:1000; Bethyl Laboratories), rabbit anti-TUJ1 (1:1000; Sigma), mouse anti-BrdU (1:1000; Millipore), rat anti-BrdU (1:1000; Abcam), rabbit anti-CUX1 (1:100; Santa Cruz Biotechnology), rabbit anticleaved caspase-3 (1:1000; Cell Signaling Technology), rabbit anti-PAX6 (1:1000; Millipore), mouse anti-MAP2 (1:1000; Millipore), mouse anti-NESTIN (1:1000; Millipore), rabbit anti-KI67 (1:1000; Abcam), mouse anti-SATB2 (1:300; Abcam), rabbit anti-SP5 (1:200; Bioss), rabbit anti-TBR2 (1:1000; Abcam), rat anti-CTIP2 (1:1000; Abcam), and mouse anti-SOX2 (1:1000; R&D Systems). Secondary antibodies applied were conjugates of Alexa Fluor Cy3, Cy5, or 488 (1:1000; Jackson ImmunoResearch). 4,6-Diamidino-2-phenylindole (DAPI) (2 mg/ml; Sigma) was used for nuclear staining.

Protein was extracted from brain cortical tissue of mouse or cultured cells by lysing with radioimmunoprecipitation assay buffer (Solarbio), with 10 mM phenylmethylsulfonyl fluoride and a protease inhibitor cocktail (Sigma, P8340). Samples were then ultrasonicated and centrifuged at approximately 12,000 rpm for 15 min at 4C. Subsequently, the supernatants were gathered, and protein concentrations were determined using a BCA kit (Thermo Scientific). Next, similar amounts of protein samples were size-separated by 6 to 12% SDSpolyacrylamide gel electrophoresis gels and shifted onto nitrocellulose membranes (Whatman) making use of a semidry transfer system (Bio-Rad). We run multiple gels and normalized to a control. The primary antibodies applied in the Western blots are listed here: rabbit anti-TRPM2 (1:1000; Bethyl Laboratories and Novus Biologicals), rabbit antitotal -catenin (1:1000; Cell Signaling Technology), rabbit antiP-catenin (S33/S37/T41) (1:1000; Cell Signaling Technology), rabbit antinonP-catenin (S33/S37/T41) (1:1000; Cell Signaling Technology), rabbit anti-PCNA (1:500; Santa Cruz Biotechnology), rabbit anti-TUJ1 (1:1000; Bioward), rabbit anti-SP5 (1:500; Bioss), rabbit anti-PH3 (1:1000; Cell Signaling Technology), rabbit anti-TBR2 (1:1000; Abcam), and rabbit anti-Flag (1:1000; Sigma). Secondary antibodies were 800CW Donkey Anti-Mouse IgG (immunoglobulin G), 800CW Donkey Anti-Rabbit, 680LT Donkey Anti-Mouse IgG, and 680LT Donkey Anti-Rabbit IgG (LI-COR Biosciences). Odyssey v3.0 software was used to scan and quantify Western blot bands.

Total RNA was obtained using TRIzol (Invitrogen, 15596) following the manufacturers directions. Reverse transcription of mRNA to first-strand cDNA was achieved using the FastQuant RT Kit (TIANGEN). Quantitative RT-PCR was conducted using the SYBR Green PCR Kit (Takara) with an ABI PRISM 7500 sequence detector system (Applied Biosystems). All reactions were repeated in triplicate for each sample. The primer sequences used for RT-PCR are listed here: TRPM2, AAGGAACACAGACAATGCCTG (forward) and AGGATGGTCTTGTGGTTCGC; TRPM3, TACACCAAAGTCAGCTCCCTG (forward) and GGCCTCTCGTGGAAAGTCAT (reverse); TRPM7, CCCAGCCAAGTTGCAAAAGT (forward) and CTACAGCTTTCTGCTTGCACC (reverse); TRPM8, GTCCTGTGACACCGACTCTG (forward) and CAGTGAGAATCCACGCACCT (reverse); TRPV1, CTCGGATGAATCTGAGCCCC (forward) and GACAACAGAGCTGACGGTGA (reverse); TRPV3, AGTGCTTATAGCAGCGGGTG (forward) and CGTGCAGGATGTTGTTTCCC (reverse); TRPV4, TCCTCTTCTCTTTCCCCGGT (forward) and GTGCCGTAGTCGAACAAGGA (reverse); ANO1, CGAGAAGTACTCGACGCTCC (forward) and TAGTCCACCTTCCGTTTGCC (reverse); TRPA1, TCTGCATATTGCCCTGCACA (forward) and ACTTTCATGCACTCGGGGAG (reverse); BDNF, TACCTGGATGCCGCAAACAT (forward) and GCCTTTGGATACCGGGACTT (reverse); PACAP, ATGACCATGTGTAGCGGAGC (forward) and CGCTGGATAGTAAAGGGCGT (reverse); -catenin, ATCACTGAGCCTGCCATCTG (forward) and GTTGCCACGCCTTCATTC (reverse) (39); SP5, GGCAAGGTGTACGGCAAAAC (forward) and CATAGGTCCCGCGGATTCTC (reverse); REST, GTGCGAACTCACACAGGAGA (forward) and AAGAGGTTTAGGCCCGTTGT (reverse) (41); Hes5, CGCATCAACAGCAGCATAGAG (forward) and TGGAAGTGGTAAAGCAGCTTC (reverse); CyclinD1, GCCTACAGCCCTGTTACCTG (forward) and ATTTCATCCCTACCGCTGTG (reverse) (42); SOX2, GCACATGAACGGCTGGAGCAACG (forward) and TGCTGCGAGTAGGACATGCTGTAGG (reverse); Foxg1, GGCAAGGGCAACTACTGGAT (forward) and CGTGGTCCCGTTGTAACTCA (reverse); Olig2, GGTGTCTAGTCGCCCATCG (forward) and AGATGACTTGAAGCCACCGC (reverse); -actin, GGTGGGAATGGGTCAGAAGG (forward) and AGGAAGAGGATGCGCCAGTG (reverse).

ChIP was performed as follows. To generate the cross-link, in vitro cultured cells were processed with 1% formaldehyde and maintained at room temperature for 10 min. Subsequently, 2.5 M glycine was then added to terminate the cross-link reaction. After washing three times with sterile PBS, the cells were gathered in lysis buffer. Next, the lysates were incubated with 15 l of Dynabeads Protein G (Invitrogen), which was incubated at least 12 hours with 1 g of specific antibody at 4C before incubation. After washing three times with low- and high-salt buffer, the DNA-protein-antibody complex was incubated overnight at 65C to open the covalent bond. Genomic DNA was then obtained using the TIANamp Genomic DNA Kit (TIANGEN Biotech) for subsequent real-time PCR analysis. The primer sequences applied for SP5 promoter are listed here: SP5-CDS, GGCAAGGTGTACGGCAAAAC (forward) and CATAGGTCCCGCGGATTCTC (reverse); SP5-0.5k, AGCTCGGTTGTGGGAGGAA (forward) and TCTTGACAAGCCGCTTGAAG (reverse); SP5-1k, ACCGCTGCCAGGTCGCT (forward) and AGGCAGGGTCAGTCGGC (reverse); SP5-2k, GCTGGGAACCGGTGGCT (forward) and TTGGGAGTATCCTCTTTGGC (reverse); CyclinD1-CDS, TCAAGACGGAGGAGACCTGT (forward) and TTCCGCATGGATGGCACAAT (reverse); CyclinD1-0.5k, CAGCCTCTTCCTCCACTTCC (forward) and AAGCCCTTCTGGAGTCAAGC (reverse); CyclinD1-1k, TCTACTTTAACAATGGTTTGCTGT (forward) and ACAGGGGAAGTCTTGAGAAGG (reverse); CyclinD1-2k, TCAGACATGGCCCTAAACCT (forward) and CATGACCAGTGTGACTCAAAGC (reverse); Axin2-CDS, CAAATGCAAAAGCCACCCGA (forward) and TGCATTCCGTTTTGGCAAGG (reverse); Axin2-0.5k, TACACACTCCCACCACCGA (forward) and ATCTCTGCTCACAGTTTCGGA (reverse); Axin2-1k, TGGAATGCAGTCTATCCCAGC (forward) and AGAAGCTGTGTGACCAGCCA (reverse); Axin2-2k, CCACCACAATCATCCTGGGT (forward) and TCAACTTTAAGGACTGAGGCCA (reverse).

Global transcriptome analysis was conducted by Annoroad Company. Total RNA samples were first tested for quality and quantity using an Agilent 2100 bioanalyzer. After building the library, high-throughput sequencing was used with the Illumina HiSeq 2500 platform. Our RNA-Seq data were deposited in the Gene Expression Omnibus database with the accession number of GSE113954.

The CRISPR-Cas9 system was used to construct TRPM2 knockout mice. During the process, two guide RNAs (gRNAs) (gRNA5, GCCAGTTCTTCTCCGGTCCAAGG; gRNA3, TATTGCTTCGTCGGAGATTGGGG) were used to cleave the whole genome sequence of TRPM2 to approximately 800 base pairs (bp). The genotyping primers designed for the TRPM2 knockout mice were TRPM2-2717F GAAGGGAAACGGGTGGATGT and TRPM2-4007R GCAGGTCTCCTCAACCAGTC. The length of PCR product was 511 or 1291 bp for TRPM2 knockout mice or wild-type mice, respectively.

Apoptotic cells were identified with immunostaining using an antibody targeting cleaved caspase-3.

293FT cells (4 104) were seeded into a 24-well plate and transfected with 0.5 g of luciferase plasmid containing an SP5 promoter and empty vector or with 0.5 g of luciferase plasmid containing an SP5 promoter and -catenin overexpression vector, using GenEscort I (Nanjing Wisegen Biotechnology). Thirty-six hours after transfection, luciferase activity was measured using the Dual-Luciferase Assay System (Promega) and GloMax 96 Microplate Luminometer (Promega).

All images were taken with a Zeiss LSM780 confocal microscope and analyzed with Photoshop CS6 (Adobe). ZEN 2010 was applied for image acquisition and processing. Brightness or expression quantity was measured using ImageJ when needed.

All statistical analyses in this study were performed and plots were generated using GraphPad Prism7.0 software. Results are represented as means SEM. Two-tailed Students t tests and one-way analysis of variance (ANOVA) were used for statistical comparisons. The differences were regarded as statistically significant with *P < 0.05, **P < 0.01, and ***P < 0.001. n.s. means not significant.

Acknowledgments: Funding: This work was supported by grants obtained from the National Science Fund for Distinguished Young Scholars (81825006), CAS Strategic Priority Research Program (XDA16010301), National Key R&D Program of China (2019YFA0110300 and 2018YFA0108402), National Science Foundation of China (31730033 and 31621004), and K. C. Wong Education Foundation. Author contributions: Y.L. performed the experiments, analyzed data, and wrote the manuscript. J.J. conceived and supervised this project. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.

View post:
Deficiency of TRPM2 leads to embryonic neurogenesis defects in hyperthermia - Science Advances

Read More...

Hydrogel controls inflammation to speed healing – Futurity: Research News

Wednesday, January 1st, 2020

Share this Article

You are free to share this article under the Attribution 4.0 International license.

Researchers have established a baseline set of injectable hydrogels that show promise to help heal wounds, deliver drugs, and treat cancer.

Critically, theyve analyzed how the chemically distinct hydrogels provoke the bodys inflammatory responseor not.

The researchers designed the hydrogels to be injectable and create a mimic of cellular scaffolds in a desired location. They serve as placeholders while the body naturally feeds new blood vessels and cells into the scaffold, which degrades over time to leave natural tissue in its place. Hydrogels can also carry chemical or biological prompts that determine the scaffolds structure or affinity to the surrounding tissue.

We dont want zero inflammation; we want appropriate inflammation.

The study demonstrates it should be possible to tune multidomain peptide hydrogels to produce appropriate inflammatory response for what theyre treating.

Weve been working on peptide-based hydrogels for a number of years and have produced about 100 different types, says Jeffrey Hartgerink, a chemist and bioengineer at Rice University. In this paper, we wanted to back up a bit and understand some of the fundamental ways in which they modify biological environments.

The researchers wanted to know specifically how synthetic hydrogels influence the environments inflammatory response. The two-year study offered the first opportunity to test a variety of biocompatible hydrogels for the levels of inflammatory response they trigger.

Usually, we think of inflammation as bad, Hartgerink says. Thats because inflammation is sometimes associated with pain, and nobody likes pain. But the inflammatory response is also extremely important for wound healing and in clearing infection.

We dont want zero inflammation; we want appropriate inflammation, he says. If we want to heal wounds, inflammation is good because it starts the process of rebuilding vasculature. It recruits all kinds of cells that are regenerative to that site.

The labs tested four basic hydrogel typestwo with positive charge and two negativeto see what kind of inflammation they would trigger. They discovered that positively charged hydrogels triggered a much stronger inflammatory response than negatively charged ones.

Among the positive materials, depending on the chemistry generating that charge, we can either generate a strong or a moderate inflammatory response, Hartgerink says. If youre going for wound-healing, you really want a moderate response, and we saw that in one of the four materials.

But if you want to go for a cancer treatment, the higher inflammatory response might be more effective, he says. For something like drug delivery, where inflammation is not helpful, one of the negatively charged materials might be better.

Basically, were laying the groundwork to understand how to develop materials around the inflammatory responses these materials provoke. That will give us our best chance of success.

Researchers at Texas Heart Institute (THI) helped analyze the cellular response to the hydrogels through multidimensional flow cytometry.

The results of this work lay the groundwork for specifically tailoring delivery of a therapeutic by a delivery vehicle that is functionally relevant and predictable, says Darren Woodside, vice president for research and director of the flow cytometry and imaging core at THI. Aside from delivering drugs, these hydrogels are also compatible with a variety of cell types.

One of the problems with stem cell therapies at present is that adoptively transferred cells dont necessarily stay in high numbers at the site of injection, he says. Mixing these relatively inert, negatively charged hydrogels with stem cells before injection may overcome this limitation.

Hartgerink says the work is foundational, rather than geared toward a specific application, but is important to the long-term goal of bringing synthetic hydrogels to the clinic.

We have been speculating about a lot of the things we think are good and true about this material, and we now have more of a sound mechanistic understanding of why they are, in fact, true, Hartgerink says.

The research appears in Biomaterials.

Additional coauthors are from Rice and the Texas Heart Institute. The National Institutes of Health, the Welch Foundation, the Mexican National Council for Science and Technology, the National Science Foundation, and a Stauffer-Rothrock Fellowship supported the research.

Source: Rice University

Originally posted here:
Hydrogel controls inflammation to speed healing - Futurity: Research News

Read More...

OncoImmune Announces Approval of IND Application for ONC-392 The anti-CTLA-4 Antibody that Preserves CTLA-4 Recycling for Better Safety and Efficacy…

Wednesday, January 1st, 2020

DetailsCategory: AntibodiesPublished on Wednesday, 01 January 2020 12:23Hits: 302

ROCKVILLE, MD, USA I December 30, 2019 I OncoImmune, Inc. announced today that its Investigational New Drug (IND) application for ONC-392, its novel, next generation anti-CTLA-4 antibody, has been approved by the U.S. Food and Drug Administration (FDA). The IND approval enables OncoImmune to begin a Phase 1A/1B clinical trial of ONC-392 that is designed to assess the safety, pharmacokinetics, and efficacy of ONC-392 as a single agent in advanced solid tumors and in combination with anti-PD(L)1 standard of care in Non-

ONC-392 was developed based on the research of OncoImmunes Founders, Drs. Yang Liu and Pan Zheng, who proposed a new theory to improve both the efficacy and safety of immunotherapy drugs. The theory calls for preservation of the CTLA-4 immune checkpoint for safer and more effective immunotherapy. (https://www.sciencedirect.com/science/article/pii/S0165614719302639). This groundbreaking research was published in three papers in Cell Research in 2018 and 2019. The two 2018 papers were recognized with the Sanofi-Cell Research Outstanding Paper Award of 2018 (https://www.nature.com/articles/s41422-019-0248-2).

ONC-392 is OncoImmunes second drug product candidate and the approval of this IND is an important milestone for OncoImmune, said Yang Liu, President and CEO of OncoImmune. Unlike other anti-CTLA-4 antibodies that cause lysosomal degradation of CTLA-4, ONC-392 preserves CTLA-4 recycling and thus maintains CTLA-4 function outside of the tumor microenvironment while allowing more effective CTLA-4-targeted depletion of regulatory T cells within the tumor. The truly novel and differentiated mechanism of action of this drug has the potential to improve therapeutic outcomes while significantly reducing toxicity.

We are very excited to test the potential of this novel antibody in cancer patients, said Pan Zheng, Chief Medical Officer of OncoImmune, Inc.

The CMC development and GMP manufacturing of the drug substance and drug product were performed by WuXi Biologics, a leading global open-access biologics technology platform for the ONC-392 program. Throughout the development program from DNA to IND, we were very impressed by WuXi Biologics expertise and professionalism, and we could not have picked a better partner for this project, said Martin Devenport, OncoImmunes Chief Operating Officer.

About OncoImmune, Inc.

OncoImmune (www.oncoimmune.com) is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel immunotherapies for cancer, inflammation and autoimmune diseases. OncoImmune is based in Rockville, Maryland.

OncoImmunes lead product, CD24Fc, is a novel therapeutic that regulates host inflammatory response to tissue injuries and which has broad implications in the pathogenesis of cancer, autoimmune disease, metabolic syndrome and graft-versus-host disease (GvHD). CD24Fc has completed a Phase IIa trial for the prophylactic treatment of acute Graft versus Host Disease (GvHD) in leukemia patients undergoing hematopoietic stem cell transplantation (HSCT) and resulted in a significant improvement in 180 Day Grade III-IV GVHD Free Survival, the Phase III primary endpoint. CD24Fc prophylaxis also resulted in a reduced relapse and, compared to match controls, CD24Fc demonstrated improvement in Overall Survival, Non-Relapse Mortality and Relapse-Free Survival. A dose-dependent reduction in severe (Grade > 3) mucositis was also observed. A 20 patient open label dose expansion cohort at the recommended clinical dose is fully enrolled and the drug continues to perform very well. A Phase III study is anticipated to start in early 2020.

SOURCE: OncImmune

Read this article:
OncoImmune Announces Approval of IND Application for ONC-392 The anti-CTLA-4 Antibody that Preserves CTLA-4 Recycling for Better Safety and Efficacy...

Read More...

Whats The Real Difference Between Organic And GMO? – Forbes

Saturday, December 21st, 2019

As the new year approaches, food is front and centerits stocked in our homes for gatherings with friends, offered at office holiday parties and constantly on our minds as we plan menus for family dinners or brainstorm next years healthy eating plan. Its a seasonable time to consider what happens to your food before it hits your plate. And for many consumers, thats something of a puzzle, particularly when it comes to understanding organic versus GMOsor genetically modified organisms.

Getty Images

Asking questions like Is organic non-GMO? and How do GMOs compare to organic food? can help you make better sense of what youre feeding yourself and your loved ones. Heres a helpful guide to boost your knowledge and inform your nutritional choices all year round.

The World Health Organization (WHO) defines GMOs as organisms whose genetic materialor DNAhas been altered or modified in some way that does not occur naturally. In most cases, genetic engineering works by transferring individual genes from one organism to another. Most commonly found in crops such as soybeans, corn and canola, GMOs are designed to provide a higher nutritional value to food, as well as protect crops against pests.

Organic foods, on the other hand, do not contain any pesticides, fertilizers, solvents or additives. According to the Organic Trade Association (OTA), USDA-certified organic foods are grown and processed according to strict federal guidelines that cover everything from soil quality and pest control to animal raising practices. Similarly, organic livestock raised for meat, eggs and dairy products must be given organic feed, and cannot receive antibiotics, growth hormones or any animal by-products.

Is organic non-GMO?

Theres plenty of debate surrounding GMO and organic food, which can make grocery shopping around the holiday season a harrowing experience. Making a key distinction can go a long way.

For those looking to avoid the use of chemical pesticides, along with the high costs of organic food, non-GMO products are a viable alternative. Thats because non-GMO products dont contain any GMO ingredients. However, that doesnt mean they are grown organically.

Organic isand always has beennon-GMO, says Laura Batcha, CEO and executive director of the OTA. But non-GMO is not always organic.

Understanding the pros and cons of both options can also empower consumers. Heres how industry experts weigh in:

Why GMO?

Why organic?

A critical eye

So what are the shortcomings of GMOs and organic items? Common arguments against GMOs include the consumption of harmful bacteria and toxins, increased risk of allergic reaction and outcrossing, or the mixing of crops from conventional seeds with GM crops, which may have an indirect effect on food safety and food security, reports WHO.

Opponents of organic food argue that its significantly more expensive than GMO or non-GMO foods, has a shorter shelf life compared to GMO foods and may have higher bacteria levels due to limited pesticide and herbicide usage.

How to make the right choice for you and your family

Both categories of foodnon-GMO and organicare subject to strict regulatory guidelines and have gone through rigorous verification programs. That alone may provide consumers with the peace of mind theyre looking for when holiday grocery shopping.

If organic is the way you want to go, Batcha offers these tips to get the best bang for your buck:

Shop smart: Look for specials on organic products, and buy in bulk whenever you can to cut costs.

Prioritize: Think about what your family eats a lot of, and what your healthy eating priorities are.

Comparison shop: Organic fresh produce is sometimes sold at the same price as conventional, so check out organic produce aisles.

Pick and choose carefully: While conventional milk can be cheaper, recent research published by Cambridge University Press suggests that organic milk is free of pesticide and antibiotic residues. If your family drinks milk, its worth the extra cost to buy organic.

A little common sense goes a long way, too. Cookies, cakes and other sugar-laden treats, even if organic, are still not the healthiest option. And if you really want to know what youre eating, try cooking from scratcheven if it means incorporating some DIY cooking hacks. Understanding the differences between organic vs. GMO foods will allow you to provide your loved ones with the right nutritional options.

Continued here:
Whats The Real Difference Between Organic And GMO? - Forbes

Read More...

2020s visions: We’ll get flying cars just before becoming software-based people – CNET

Saturday, December 21st, 2019

UberAir is planning on taking to the skies over Melbourne by 2020, even if that seems highly ambitious.

In some ways, the future that so much science fiction promised us is already here. We have genetically altered humans, conversations with computers and robots that run around the woods and do backflips.

But the decade beginning in 2020 will take us even further toward a world where far-out ideas like hooking brains up to computers -- and even immortality -- become topics of serious conversation.

Vivek Wadhwa, author of the 2017 book The Driver in the Driverless Car, expects that along the way, several other major advances will be in common use by 2030, including the ever-delayed flying car, medical tricorders, bionic exoskeletons and unlimited clean energy.

"Some technologies will take longer to reach the masses than others, but they will be at hand," he tells me. "The 2020s will be when the incredible promises of technology finally happen."

As 2019, the year in which Blade Runner was set, draws to a close, here's a deeper look at what the next 10 years will bring.

Predicting that George Jetson's or Rick Deckard's favored method of commuting is just around the corner has become the ultimate futurist's faux pas, but here we are again. The barrier to flying around town isn't technology at this point; it's laws and logistics. A number of small companies make flying cars right now, but most require a pilot's license and might cost as much as a helicopter, preventing airborne autos from becoming a replacement for the average driver's Prius anytime soon.

What could happen for the rest of us is a system of flying taxis. Uber hopes to beta-test limited flight-sharing in select cities using small, electric VTOL (vertical takeoff and landing) vehicles as soon as 2023.

Now playing: Watch this: Bell Nexus flying taxi could hit the skies next year

1:18

The driverless future will arrive much sooner. A Tesla can already valet-park itself and take the wheel on the highway -- not completely self-driving, but a start. Several other automakers aim to catch up in the next few years, moving toward fully autonomous driving by the mid-2020s. There's even been a rumor that Apple could create a driverless electric car that adds augmented reality or some sort of smart displays to the concept by 2025.

But engineer, inventor and former BT "futurologist" Ian Pearson sees our self-driving destiny playing out differently.

"I think there's going to be a shock in the 2020s on that one," he says.

Pearson envisions bans on personal cars in city centers in favor of electric "pods" (sometimes called personal rapid transit) that would be inexpensive and basic -- perhaps akin to big, covered golf carts -- running on designated roadways and controlled from riders' phones.

The future of moving around cities could be pods like these in use at London's Heathrow Airport.

If you're looking to go farther than just across town, Elon Musk has promised he'll be ready to ferry us around the globe on super-fast flights via space using the same rockets he hopes will begin carrying humans to the moon and Mars in the 2020s.

Musk has always been a little loose with meeting self-imposed timelines -- SpaceX took several years longer to get its commercial space business off the ground than the founder initially promised -- so it's tough to say how soon regular folks might be catching a ride on his Starship. Other space companies like Virgin Galactic and Blue Origin are closer to ferrying space tourists in the next few years, at least for a quick joyride in the skies.

Now playing: Watch this: First look inside Virgin Galactic's space passenger terminal

1:26

The 2020s are opening with millions speaking to digital assistants, and the decade will see the ways we interact with computers evolve and even surpass how we communicate with other humans.

Bill Gates said earlier this year that natural language inputs and AI voice assistants will improve to the point they might be able to fill the role of a human secretary.

"I do think that we'll have executive assistant-type capability in a five- to 10-year period," Gates told MIT Technology Review in the above video.

Pearson thinks that instead of talking to smart speakers or phones, we could soon be conversing with our own eyeballs. He says he first thought up the idea for an "active contact lens" back in 1991. The notion of an augmented reality display floating on your cornea would have been perfect cyborg sci-fi movie fodder back then, but now at least one startup seems to have it just about worked out, with a tiny display that seems just right for embedding in contacts.

We'll soon see if hiding your screen on your eyeball is appealing, but Elon Musk is already thinking one step ahead. His startup Neuralink is just one outfit working on brain-computer interfaces that use our thoughts as input mechanisms rather than taking the time to type, speak or gesture our commands.

Musk hopes to demonstrate the technology with paralyzed patients in 2020, and by 2030 it may become significantly easier to communicate with the digital world than the human sitting next to you.

In 2030, artificial intelligence may be as smart as your biological friends.

"I think that in three to five years you will see a computer system that will be able to autonomously learn how to understand," IBM Watson lead developer David Ferrucci says in 2018's Do You Trust This Computer. "Not unlike the way the human mind works."

Famed futurist Ray Kurzweil has been claiming for years we'll have humanlike AI by 2029. He doesn't see it, though, as the start of the robot apocalypse (as some, including the late Stephen Hawking, have predicted), but rather as a new era of liberation from the limitations of human biology.

Now playing: Watch this: Ray Kurzweil at SXSW

18:31

Kurzweil laid out his vision in his 2005 book The Singularity is Near, and he's doubled down on it over the years. His basic idea is that advanced AI and nanotechnology will perfect our bodies and enhance our brains in such a way that we're not cyborgs, but our best selves: funnier, smarter, sexier and resistant to disease. But that's just the beginning.

All this comes, according to Kurzweil, by 2029, just in time for a new era when we can upload our minds to become fully software-based people, leaving our bodies behind to live forever in the cloud.

But that's predicted for the 2030s. You'll have to check back in a decade for how that pans out.

The genetic engineering genie has been let out of its bottle, with the first children allegedly born from engineered embryos living anonymously somewhere in China today.

Less illicit uses of gene-editing technologies like CRISPR/Cas9 (which acts like a pair of molecular scissors for DNA) will continue to move forward to help tackle disease and force us to wrestle with the ethical questions involved in the inevitable era of "designer babies" who have their genes altered to match the whims and desires of their parents.

Now playing: Watch this: CRISPR explained with crisps (and assorted snacks)

3:36

Zoltan Istvan, author and Republican candidate challenging President Trump for the 2020 GOP nomination, says an emerging related technology called in vitro gametogenesis could soon shift how we approach infertility and having children. The process basically allows for sperm or eggs to be created from an individual's stem cells.

"It could change how women approach their lives, since they will no longer be on a timetable. ... They'll be able to have children at any age," he tells me. "This tech can also be used for men, and individuals may not even need partners anymore to have children."

Istvan expects the approach could be tested on humans within two to four years and commercially available by 2027.

In the meantime, look for more medical innovations, like a male birth control pill, chips implanted in the brain to give memory a boost and 3D-printed organs.

It's easy to go down the rabbit hole of optimistic outcomes, but there's also a darker timeline to consider. We may already be witnessing the opening scenes of multiple tragedies that could play out over the next decade. Here are just a few:

SpaceX alone hopes to nearly quintuple the 8,000 satellites launched since the dawn of the space age by middecade. Its competitors aim to launch their own mega-constellations of hundreds or thousands more satellites. Collisions in a congested orbital space over Earth could lead to a worst-case scenario called "Kessler syndrome," in which orbit becomes so full of debris it's no longer safe for astronauts or satellites. We would say goodbye to GPS, satellite communications and space exploration for some time.

This image of a distant galaxy group from Arizona's Lowell Observatory is marred by diagonal lines from the trails of Starlink satellites shortly after their launch in May.

At this point, most experts agree that better robots, artificial intelligence and automation will displace millions of workers in the 2020s. The impact on society and what we do about it may shape the coming years.

Istvan and Democratic presidential candidate Andrew Yang are among the politicians already campaigning on the issue of implementing a universal basic income as a safety net for those who inevitably lose their jobs to tech.

And what about all the potential nightmares we're already navigating online, from deepfakes to concerns over privacy?

"Advances in artificial intelligence will open up new opportunities for mass surveillance and mass-manufactured emotional manipulation," Interchain Foundation President and Tendermint CEO Jae Kwon says. "It will get worse before it gets better."

I've ignored the elephant on the barstool in the corner: a climate and environmental crisis that's already in motion and stirring up deadly extreme weather events with increasing frequency and leaving plastic waste in nearly every nook and cranny of the planet.

To echo Kwon, this also will get worse before it gets better.

Now playing: Watch this: The world's most dangerous lake is finally getting a...

2:37

But technology loves nothing more than a big problem to solve, and plenty of possible solutions could take off in the next decade. It may be the long-promised holy grail of clean fusion power, or the notion of replacing all those planet-warming fossil fuels with the very carbon dioxide that they produce (technologies already exist to capture CO2 and convert it into raw materials).

"I also think we'll see some quite advanced materials arriving, like spray-on solar [photovoltaic power] films," Pearson says. "We'll also see water supply being solved in the developing world with desalination and water collection tech."

Author and MIT scientist Andrew McAfee is so confident technology will help us turn around the mass consumption streak weighing so heavily on the environment that he's inviting people to take him up on a bet the US will consume less energy in 2029 than it does in 2019.

So far, no one has taken that bet. Interestingly, Kurzweil has put down money on his own bet that a machine will pass a test of "human-level intelligence" by 2029.

Let's plan to meet back here in a decade to see who's right. Or just look me up in the cloud.

Follow this link:
2020s visions: We'll get flying cars just before becoming software-based people - CNET

Read More...

Viewpoint: Confused about GMOs and pesticides? Here’s a science-based handbook for combating anti-biotech fallacies – Genetic Literacy Project

Saturday, December 21st, 2019

Junk science is everywhere these days. From scare stories about pesticides to allegations that genetic engineering threatens humanitys future, the internet teems with misinformation about food, farming and biotechnology. A recent (and very disappointing) example comes from the usually reputable Scientific American. In August, the news outlet ran an opinion piece claiming that vegetables today are less nutritious and more toxic than they were in years past:

Why are nutrients in our food declining? Well, for one, we are killing the soil it grows in. Prodigious use of biocides (herbicides, insecticides, fungicides, as well as synthetic chemical fertilizers and antibiotics) kill or disrupt soil microorganisms that allow plants to absorb nutrients. Also, increased atmospheric CO2 is accelerating photosynthesis; plants grow faster but contain fewer nutrients, which is expected to lead to worldwide nutrient deficiencies. Vegetables becoming more like sugary snacks? Not good.

Experts quickly pounced on Scientific American for running an article filled with so many inaccuracies, which was later updated to address some of this criticism. For the record, no, your vegetables arent morphing into sugary snacks, and pesticides arent killing the soil. Theyre a necessary part of any farming systemand becoming more environmentally friendly as time goes on. This story was but one example of the mass of misinformation that proliferates online, poisoning discussions about important technologies and threatening to grind innovation in agriculture to a halt.

With so much on the line, scientists are pushing back against the misinformation onslaught. My colleagues William Kerr and Peter Phillips at the University of Saskatchewan and I are aiding that effort with a new book that takes on a variety of common myths surrounding food production and crop biotechnology: GM Agriculture and Food Security: Fears and Facts.

As academics, the three of us have researched and written about agriculture, biotechnology, food and innovation for more than 20 years, with over 400 publications between us. We certainly dont know everything, but we wanted to share our insights with those interested in separating sound science from media and activist hype.

Do farmers really need pesticides?

Have you ever wondered why farmers use chemicals in their fields? To inform readers about the reasons for farm pesticide use, we discuss how proficiently weeds produce seeds compared to domesticated plants. Weeds frequently produce 1,000 seeds or more every summer. Kochia, a noxious weed in all parts of Canada, is capable of producing 25,000 seeds per year. By comparison, a really good head of wheat produces 40 seeds, but would normally produce 25-35. If farmers didnt use chemicals to control weeds, within a few years, weeds would dominate the entire field, making it difficult to grow a crop.

How GMOs help save our forests

Perhaps youve also pondered how we will sustainably feed 10 billion people, the projected global population by 2050, without cutting down millions of acres of forest. Currently, roughly 800 million people dont get enough to eat on a daily bases, so we felt it was necessary to discuss how innovations in food production have already sustainably increased crop yields around the world, and are poised to continue doing so.

Hawaiis papaya industry was decimated in the 1990s by a disease known as ring-spot virus. Virus-resistant papaya varieties have since allowed Hawaiian farmers to not just save their livelihood but actually increase their production. Likewise, newly developed gene-edited sorghum doubled crop yields of this African staple food in a recent study, fueling expectations that CRISPR is going to have a revolutionary impact on agriculture.

A related question, often asked and answered by organic farming proponents, is whether locally sourced food is capable of meeting the increasing global demand for calories. Many people enjoy the fruits and vegetables they grow in their backyard gardens, so the romantic notion that locally produced food is capable of combating hunger around the world sounds plausible. But we highlight the many reasons why local food self-sufficiency should not be viewed as equivalent to food security.

Food processing is essential to ensure harvest production spikes are leveled out, thus preventing food price spikes months later. Societies that are forced to rely on locally produced crops are more likely to face market disruptions and food insecurity as a result. The discrepancy between popular ideas about sustainable farming and what science says on the topic leads us to another issue worth exploring.

The assault on expertise

400 years ago, Galileo was castigated by the authorities of the day for arguing that the sun, not the Earth, was the center of our universe. We sometimes doubt that much has changed over the last four centuries, as todays experts are often ridiculed for defending scientific facts against attacks from ideological activist groups.

The three of us strongly believe that consumers should know who the experts are: people with degrees who spend their careers conducting original research. This is essential because the discussion around crop biotechnology has become a pitched political battle as anti-GMO activists continue to spin conspiracies to undermine the credibility of academically trained scientists. The work of US Right to Know, an organic industry-funded special interest group, illustrates this point. The anti-GMO outfit has filed freedom of information requests on over 50 university faculty that have published peer-reviewed journal articles that quantify the benefits of GM crops. Two of us belong the group of academics that USRTK has targeted. Our private communications were posted online out of context, and this information has been used to accuse us of shilling for the biotech industry.

To help combat the assault on expertise, we examine the difference between science and opportunistic activism. Science, simply put, is a process that leads to compilations of knowledge. As research methods are agreed to and standardized, carefully conducted experiments expand our understanding of a given scientific topic. Activism, meanwhile, involves cherry picking data that fits a predetermined conclusion. Claims that the weed killer glyphosate cause cancer are often justified with reference to such cherry-picked research.

This isnt to say a new study that contradicts all of the known literature is incorrect, but it should trigger additional research to confirm, or reject, the new findingsbefore activist groups and the press promote any particular conclusion.

What you should know about factory farming

An equally important topic of discussion is so-called industrial agriculture. Many urban consumers that no longer enjoy close connections to agriculture tend to view farms as small, red-barn operations, like the ones our grandparents generation ran. The reality of todays multi-thousand acre, million-dollar-equipment farms is largely incomprehensible to most consumers, which needs to change if society is going to have an informed conversation about the benefits and challenges of modern food production.

While we highlight the economic and environmental benefits from the commercialization of GM crops in various countries, the consolidation within the seed development industry raises legitimate concerns. For example, the increased cost of obtaining regulatory approval for GM crop varieties has become so high that public university researchers are beginning to avoid genetic modification as a plant breeding technology. The regulatory headache and expense are simply not worth it to them.

Meanwhile, much of society is fixated on consolidations at the start of food supply chains, rather than consolidations that have occurred within the food processing and retail sectors. Companies such as Kraft and Walmart have far more influence over the products available in grocery stores than the agricultural firms at the start of the supply chain, yet virtually no attention is given to firms that are closer to consumers.

Mergers and acquisitions within the grocery retail sector can lead to increased market power in the hands of a few large, global firms, which in turn creates the potential for higher prices due to reduced competition. Retail firms have far more power over the price we consumers pay for food than the firms at the start of food supply chains.

Focus on the future

The internet has put limitless amounts of information at our fingertips. Sadly, much of it is misinformationjunk science meant to skew our perception of important topics like food safety and biotechnology. The risk this poses cannot be overstated.

Producing an abundant food supply to economically and sustainably feed a world population of 9+ billion people is a Herculean task. Innovative plant breeding technologies can help us do it, but these advances are being threatened by arduous, unnecessary regulations and deliberate misinformation campaigns led by activist who see mainstream science as a threat to humanity. The only long-term solution is an informed populace that wont be fooled by propaganda.

Stuart J. Smyth is a professor in the Department of Agricultural and Resource Economics and holds the Industry Funded Research Chair in Agri-Food Innovation at the University of Saskatchewan. Follow him on Twitter

Read the original:
Viewpoint: Confused about GMOs and pesticides? Here's a science-based handbook for combating anti-biotech fallacies - Genetic Literacy Project

Read More...

Page 24«..1020..23242526..30..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick